nlm_download_date_description,study_first_submitted_date,results_first_submitted_date,disposition_first_submitted_date,last_update_submitted_date,study_first_submitted_qc_date,study_first_posted_date,study_first_posted_date_type,results_first_submitted_qc_date,results_first_posted_date,results_first_posted_date_type,disposition_first_submitted_qc_date,disposition_first_posted_date,disposition_first_posted_date_type,last_update_submitted_qc_date,last_update_posted_date,last_update_posted_date_type,start_month_year,start_date_type,start_date,verification_month_year,verification_date,completion_month_year,completion_date_type,completion_date,primary_completion_month_year,primary_completion_date_type,primary_completion_date,target_duration,study_type,acronym,baseline_population,brief_title,official_title,overall_status,last_known_status,phase,enrollment,enrollment_type,source,limitations_and_caveats,number_of_arms,number_of_groups,why_stopped,has_expanded_access,expanded_access_type_individual,expanded_access_type_intermediate,expanded_access_type_treatment,has_dmc,is_fda_regulated_drug,is_fda_regulated_device,is_unapproved_device,is_ppsd,is_us_export,biospec_retention,biospec_description,ipd_time_frame,ipd_access_criteria,ipd_url,plan_to_share_ipd,plan_to_share_ipd_description,created_at,updated_at,id,nct_id,mesh_term,downcase_mesh_term
"ClinicalTrials.gov processed this data on May 07, 2020",2020-04-24,NA,NA,2020-04-27,2020-04-27,2020-04-28,Actual,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-28,Actual,"February 10, 2020",Actual,2020-02-10,March 2020,2020-03-31,June 2020,Anticipated,2020-06-30,April 2020,Anticipated,2020-04-30,NA,Interventional,PEAC,,Protective Effect of Aspirin on COVID-19 Patients,Protective Effect of Aspirin on COVID-19 Patients,Enrolling by invitation,NA,Phase 2/Phase 3,128,Anticipated,Xijing Hospital,,2,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-08T09:13:48Z,2020-05-08T09:13:48Z,5820059,NCT04365309,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 07, 2020",2020-04-23,NA,NA,2020-04-26,2020-04-23,2020-04-27,Actual,NA,NA,NA,NA,NA,NA,2020-04-26,2020-04-28,Actual,"April 20, 2020",Actual,2020-04-20,April 2020,2020-04-30,"October 1, 2031",Anticipated,2031-10-01,"April 20, 2030",Anticipated,2030-04-20,NA,Observational,ACCESS,,ACCESS A Master Digital Surveillance Protocol for COVID-19,"ACCESS (American COVID-19 Collaborative, Enabling Seamless Science) Master Digital Surveillance and Associated Clinical Trials Protocol for COVID-19",Recruiting,NA,NA,1000000,Anticipated,Medable Inc.,,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,Please reach out to the study team for data sharing policies and procedures. Only de-identified and aggregate data may be considered for sharing.,2020-05-08T09:14:48Z,2020-05-08T09:14:48Z,5820270,NCT04363268,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 07, 2020",2020-04-20,NA,NA,2020-04-24,2020-04-22,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-24,2020-04-28,Actual,"April 27, 2020",Anticipated,2020-04-27,April 2020,2020-04-30,"October 27, 2020",Anticipated,2020-10-27,"October 27, 2020",Anticipated,2020-10-27,NA,Observational,NA,,Evaluation of Antibody Tests for COVID-19,Evaluation of Commerical Antibody Tests for COVID-19,Recruiting,NA,NA,1000,Anticipated,Washington University School of Medicine,,NA,4,NA,FALSE,NA,NA,NA,FALSE,NA,NA,NA,NA,NA,Samples Without DNA,"
      Plasma or serum.
    ",NA,NA,NA,NA,NA,2020-05-08T09:15:13Z,2020-05-08T09:15:13Z,5820344,NCT04360954,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 07, 2020",2020-04-13,NA,NA,2020-04-27,2020-04-17,2020-04-21,Actual,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-28,Actual,"April 25, 2020",Actual,2020-04-25,April 2020,2020-04-30,"May 1, 2021",Anticipated,2021-05-01,"December 31, 2020",Anticipated,2020-12-31,NA,Interventional,NA,,Use of UC-MSCs for COVID-19 Patients,Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients With Acute Respiratory Distress Syndrome (ARDS),Recruiting,NA,Phase 1/Phase 2,24,Anticipated,University of Miami,,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-08T09:15:43Z,2020-05-08T09:15:43Z,5820458,NCT04355728,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 07, 2020",2020-03-25,NA,NA,2020-04-27,2020-04-17,2020-04-20,Actual,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-28,Actual,"April 17, 2020",Actual,2020-04-17,April 2020,2020-04-30,"December 1, 2020",Anticipated,2020-12-01,"July 1, 2020",Anticipated,2020-07-01,NA,Interventional,THICK,,Trial of Hydroxychloroquine In Covid-19 Kinetics,A Randomized Phase 2/3 Trial of Hydroxychloroquine In Covid-19 Kinetics,"Active, not recruiting",NA,Phase 2/Phase 3,58,Anticipated,University of South Alabama,,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,TRUE,NA,,NA,NA,NA,No,NA,2020-05-08T09:15:53Z,2020-05-08T09:15:53Z,5820492,NCT04353271,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 07, 2020",2020-04-13,NA,NA,2020-04-26,2020-04-13,2020-04-16,Actual,NA,NA,NA,NA,NA,NA,2020-04-26,2020-04-28,Actual,"April 10, 2020",Actual,2020-04-10,April 2020,2020-04-30,June 2021,Anticipated,2021-06-30,June 2021,Anticipated,2021-06-30,NA,Observational,BLAST COVID-19,,Beaumont Health Large-scale Automated Serologic Testing for COVID-19,Beaumont Health Large-scale Automated Serologic Testing for COVID-19,Recruiting,NA,NA,50000,Anticipated,William Beaumont Hospitals,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,TRUE,NA,NA,FALSE,Samples With DNA,"
      Whole blood and serum
    ",NA,NA,NA,No,NA,2020-05-08T09:16:10Z,2020-05-08T09:16:10Z,5820536,NCT04349202,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 07, 2020",2020-04-08,NA,NA,2020-04-27,2020-04-08,2020-04-13,Actual,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-28,Actual,"April 8, 2020",Actual,2020-04-08,April 2020,2020-04-30,December 2021,Anticipated,2021-12-31,December 2021,Anticipated,2021-12-31,NA,Observational,NA,,COVID-19 Community Research Partnership,"A Multicenter, Prospective Study of COVID-19 Using Real-Time Syndromic Surveillance, Scheduled At-home Serologic Testing, and Electronic Health Records","Active, not recruiting",NA,NA,150000,Anticipated,Wake Forest University Health Sciences,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-08T09:16:35Z,2020-05-08T09:16:35Z,5820596,NCT04342884,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 07, 2020",2020-04-02,NA,NA,2020-04-27,2020-04-02,2020-04-06,Actual,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-28,Actual,"April 26, 2020",Actual,2020-04-26,April 2020,2020-04-30,October 2020,Anticipated,2020-10-31,October 2020,Anticipated,2020-10-31,NA,Interventional,CORON-ACT,,Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19),"CORON-ACT - a Multicenter, Double-blind, Randomized Controlled Phase II Trial on the Efficacy and Safety of Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19)",Recruiting,NA,Phase 2,100,Anticipated,"University Hospital Inselspital, Berne",,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-08T09:16:56Z,2020-05-08T09:16:56Z,5820675,NCT04335071,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 07, 2020",2020-04-02,NA,NA,2020-04-27,2020-04-02,2020-04-06,Actual,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-28,Actual,"April 15, 2020",Actual,2020-04-15,April 2020,2020-04-30,"July 31, 2020",Anticipated,2020-07-31,"June 30, 2020",Anticipated,2020-06-30,NA,Interventional,EPICOS,,Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel,Prevention of SARS-CoV-2 (COVID-19) Through Pre-Exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Hydroxychloroquine in Healthcare Personnel: Randomized Clinical Trial Controlled With Placebo,Recruiting,NA,Phase 3,4000,Anticipated,Plan Nacional sobre el Sida (PNS),,4,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-08T09:16:57Z,2020-05-08T09:16:57Z,5820677,NCT04334928,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 07, 2020",2020-03-31,NA,NA,2020-04-26,2020-03-31,2020-04-02,Actual,NA,NA,NA,NA,NA,NA,2020-04-26,2020-04-28,Actual,"March 30, 2020",Actual,2020-03-30,March 2020,2020-03-31,"December 31, 2021",Anticipated,2021-12-31,"March 31, 2021",Anticipated,2021-03-31,NA,Interventional,CORIMUNO-TOC,,CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI),Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Tocilizumab Trial - CORIMUNO-19 - TOCI (CORIMUNO-TOCI),"Active, not recruiting",NA,Phase 2,228,Actual,Assistance Publique - HÃ´pitaux de Paris,,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-08T09:17:06Z,2020-05-08T09:17:06Z,5820701,NCT04331808,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 08, 2020",2020-04-27,NA,NA,2020-04-27,2020-04-27,2020-04-29,Actual,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-29,Actual,"April 28, 2020",Anticipated,2020-04-28,April 2020,2020-04-30,April 2021,Anticipated,2021-04-30,April 2021,Anticipated,2021-04-30,NA,Observational,NA,,"ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19",ScreenNC: A Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the SARS-CoV-2 Infection,Enrolling by invitation,NA,NA,10000,Anticipated,"University of North Carolina, Chapel Hill",,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      Blood; virus from nasal or oral swab
    ",NA,NA,NA,No,NA,2020-05-09T09:11:13Z,2020-05-09T09:11:13Z,5832655,NCT04367740,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 08, 2020",2020-04-16,NA,NA,2020-04-27,2020-04-27,2020-04-29,Actual,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-29,Actual,"April 9, 2020",Actual,2020-04-09,April 2020,2020-04-30,July 2020,Anticipated,2020-07-31,July 2020,Anticipated,2020-07-31,NA,Interventional,COVID'HEMOS,,Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19,Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19,Recruiting,NA,N/A,100,Anticipated,"University Hospital, Rouen",,1,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-09T09:11:16Z,2020-05-09T09:11:16Z,5832669,NCT04367662,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 08, 2020",2020-04-28,NA,NA,2020-04-28,2020-04-28,2020-04-29,Actual,NA,NA,NA,NA,NA,NA,2020-04-28,2020-04-29,Actual,"March 20, 2020",Actual,2020-03-20,April 2020,2020-04-30,"March 31, 2022",Anticipated,2022-03-31,"March 31, 2021",Anticipated,2021-03-31,24 Months,Observational [Patient Registry],NA,,Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement,Prospective Registry for Multimodal Assessment of Neuromuscular Pathology Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection,Recruiting,NA,NA,500,Anticipated,University Hospital Tuebingen,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-09T09:11:27Z,2020-05-09T09:11:27Z,5832704,NCT04367350,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 08, 2020",2020-04-16,NA,NA,2020-04-27,2020-04-27,2020-04-29,Actual,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-29,Actual,"April 14, 2020",Actual,2020-04-14,April 2020,2020-04-30,"December 1, 2021",Anticipated,2021-12-01,"December 1, 2020",Anticipated,2020-12-01,NA,Observational,ELCOVID,,Electrocardiogram Analysis in COVID-19 Patients,Electrocardiogram Analysis in COVID-19 Patients,Recruiting,NA,NA,1000,Anticipated,University Hospital of Ferrara,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,not yet decided a plan to share individual participant data (IPD),2020-05-09T09:11:39Z,2020-05-09T09:11:39Z,5832731,NCT04367129,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-03-19,NA,NA,2020-04-21,2020-03-19,2020-03-20,Actual,NA,NA,NA,NA,NA,NA,2020-04-21,2020-04-22,Actual,"April 8, 2020",Actual,2020-04-08,April 2020,2020-04-30,May 2022,Anticipated,2022-05-31,May 2021,Anticipated,2021-05-31,NA,Interventional,SAC-COVID,,CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment,"A Randomized, Double-blind, Placebo-controlled, Multi-site, Phase III Study to Evaluate the Safety and Efficacy of CD24Fc in COVID-19 Treatment",Recruiting,NA,Phase 3,230,Anticipated,"OncoImmune, Inc.",,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-02T09:15:43Z,2020-05-02T09:15:43Z,5754569,NCT04317040,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 13, 2020",2020-05-04,NA,NA,2020-05-07,2020-05-04,2020-05-06,Actual,NA,NA,NA,NA,NA,NA,2020-05-07,2020-05-11,Actual,"May 1, 2020",Actual,2020-05-01,May 2020,2020-05-31,"May 30, 2020",Anticipated,2020-05-30,"May 20, 2020",Anticipated,2020-05-20,NA,Observational,NA,,Haemoglobin Concentration on COVID-19,An Important Index on Severity of Coronavirus Disease: Erythrocyte Haemoglobin Concentration,Recruiting,NA,NA,200,Anticipated,Nevsehir Public Hospital,,NA,3,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-14T08:54:47Z,2020-05-14T08:54:47Z,5902305,NCT04377607,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 13, 2020",2020-04-26,NA,NA,2020-05-07,2020-04-26,2020-04-28,Actual,NA,NA,NA,NA,NA,NA,2020-05-07,2020-05-11,Actual,"April 29, 2020",Actual,2020-04-29,May 2020,2020-05-31,August 2020,Anticipated,2020-08-31,May 2020,Anticipated,2020-05-31,NA,Interventional,SINK COVID-19,,Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19,Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19,Recruiting,NA,Phase 2,500,Anticipated,William Beaumont Hospitals,,3,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,TRUE,NA,,NA,NA,NA,No,NA,2020-05-14T08:55:07Z,2020-05-14T08:55:07Z,5902369,NCT04365985,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-03-23,NA,NA,2020-04-20,2020-03-23,2020-03-25,Actual,NA,NA,NA,NA,NA,NA,2020-04-20,2020-04-22,Actual,"March 28, 2020",Actual,2020-03-28,March 2020,2020-03-31,"August 30, 2020",Anticipated,2020-08-30,"August 30, 2020",Anticipated,2020-08-30,NA,Interventional,NA,,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II),Evaluation of the Safety and Clinical Efficacy of Hydroxychloroquine Associated With Azithromycin in Patients With Pneumonia Caused by Infection by the SARS-CoV2 Virus - Coalition COVID-19 Brasil II - Severely-ill Patients,Recruiting,NA,Phase 3,440,Anticipated,Hospital Israelita Albert Einstein,,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,No,NA,2020-05-02T09:15:29Z,2020-05-02T09:15:29Z,5754522,NCT04321278,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-23,NA,NA,2020-05-06,2020-04-23,2020-04-27,Actual,NA,NA,NA,NA,NA,NA,2020-05-06,2020-05-08,Actual,"April 26, 2020",Actual,2020-04-26,May 2020,2020-05-31,"June 14, 2020",Anticipated,2020-06-14,"May 31, 2020",Anticipated,2020-05-31,NA,Interventional,COMBATCOVID19,,COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19,COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19 (the COMBAT-COVID-19 Pilot Study),Recruiting,NA,Phase 2,70,Anticipated,Maimonides Medical Center,,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,No,NA,2020-05-12T09:19:27Z,2020-05-12T09:19:27Z,5888627,NCT04363437,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-04-03,NA,NA,2020-04-21,2020-04-03,2020-04-07,Actual,NA,NA,NA,NA,NA,NA,2020-04-21,2020-04-24,Actual,"April 3, 2020",Actual,2020-04-03,April 2020,2020-04-30,"July 31, 2020",Anticipated,2020-07-31,"June 3, 2020",Anticipated,2020-06-03,NA,Interventional,SRA-COV,,Renin Angiotensin System - CoronaVirus,Renin Angiotensin System - CoronaVirus,Recruiting,NA,N/A,50,Anticipated,Assistance Publique Hopitaux De Marseille,,2,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-04T09:05:40Z,2020-05-04T09:05:40Z,5776880,NCT04337008,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-04-03,NA,NA,2020-04-21,2020-04-03,2020-04-07,Actual,NA,NA,NA,NA,NA,NA,2020-04-21,2020-04-24,Actual,"April 3, 2020",Actual,2020-04-03,April 2020,2020-04-30,April 2021,Anticipated,2021-04-30,April 2021,Anticipated,2021-04-30,NA,Interventional,NA,,"Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers","Phase 1 Open-label Study to Evaluate the Safety, Tolerability and Immunogenicity of INO-4800, a Prophylactic Vaccine Against SARS-CoV-2, Administered Intradermally Followed by Electroporation in Healthy Volunteers",Recruiting,NA,Phase 1,40,Anticipated,Inovio Pharmaceuticals,,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,TRUE,TRUE,NA,NA,NA,,Anonymous IPD may be shared following or during the publication of summary data. Archival data may be accessed for up to 10 years following the end of the study.,Those who request the anonymous IPD must provide a plan of study explaining how the data will be used. Requests may be sent to the Central Contact Person. Requests will be reviewed based on the potential for the planned use of the IPD for advancing scientific knowledge and theory.,NA,Yes,Data dictionaries and all collected IPD will be stripped of identifiers and may be made available upon request.,2020-05-04T09:05:42Z,2020-05-04T09:05:42Z,5776890,NCT04336410,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-04-02,NA,NA,2020-04-22,2020-04-03,2020-04-07,Actual,NA,NA,NA,NA,NA,NA,2020-04-22,2020-04-24,Actual,"April 1, 2020",Actual,2020-04-01,April 2020,2020-04-30,"May 30, 2020",Anticipated,2020-05-30,"April 30, 2020",Anticipated,2020-04-30,1 Month,Observational [Patient Registry],MexCOVID-19,,Outcomes of Patients With COVID-19 in the Intensive Care Unit,Outcomes of Patients With COVID-19 in the Intensive Care Unit: A National Observational Study (Mexico COVID-19 ICU Study),Recruiting,NA,NA,150,Anticipated,Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,All IPD that underlie could results in a publication.,2020-05-04T09:05:43Z,2020-05-04T09:05:43Z,5776892,NCT04336345,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-04-17,NA,NA,2020-04-20,2020-04-20,2020-04-22,Actual,NA,NA,NA,NA,NA,NA,2020-04-20,2020-04-22,Actual,"April 16, 2020",Actual,2020-04-16,April 2020,2020-04-30,"August 1, 2020",Anticipated,2020-08-01,"June 1, 2020",Anticipated,2020-06-01,NA,Interventional,AVoCaDO,,Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation,"Administration of Intravenous Vitamin C in Novel Coronavirus Infection and Decreased Oxygenation (AVoCaDO): A Phase I/II Safety, Tolerability, and Efficacy Clinical Trial",Recruiting,NA,Phase 1/Phase 2,20,Anticipated,Hunter Holmes Mcguire Veteran Affairs Medical Center,,2,NA,NA,FALSE,NA,NA,NA,NA,TRUE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,No,NA,2020-05-02T09:11:47Z,2020-05-02T09:11:47Z,5753808,NCT04357782,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-04-01,NA,NA,2020-04-21,2020-04-06,2020-04-09,Actual,NA,NA,NA,NA,NA,NA,2020-04-21,2020-04-22,Actual,"April 2, 2020",Actual,2020-04-02,April 2020,2020-04-30,"April 1, 2022",Anticipated,2022-04-01,"April 1, 2022",Anticipated,2022-04-01,NA,Interventional,ESCAPE,,Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction,Efficiency in Management of Organ Dysfunction Associated With Infection by the Novel SARS-CoV-2 Virus (COVID-19) Through a Personalized Immunotherapy Approach: the ESCAPE Clinical Trial,Recruiting,NA,Phase 2,40,Anticipated,Hellenic Institute for the Study of Sepsis,,2,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-02T09:14:23Z,2020-05-02T09:14:23Z,5754295,NCT04339712,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-03-26,NA,NA,2020-04-20,2020-03-27,2020-03-30,Actual,NA,NA,NA,NA,NA,NA,2020-04-20,2020-04-22,Actual,"April 2, 2020",Actual,2020-04-02,April 2020,2020-04-30,"June 30, 2020",Anticipated,2020-06-30,"May 31, 2020",Anticipated,2020-05-31,NA,Interventional,NA,,Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS,Early Prone Positioning Combined With High-Flow Nasal Cannula Versus High-Flow Nasal Cannula in COVID-19 Induced Moderate to Severe ARDS,Recruiting,NA,N/A,346,Anticipated,Rush University Medical Center,,2,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,TRUE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-02T09:15:13Z,2020-05-02T09:15:13Z,5754459,NCT04325906,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-04-07,NA,NA,2020-04-10,2020-04-07,2020-04-09,Actual,NA,NA,NA,NA,NA,NA,2020-04-10,2020-04-14,Actual,"April 3, 2020",Actual,2020-04-03,April 2020,2020-04-30,"April 30, 2021",Anticipated,2021-04-30,"June 30, 2020",Anticipated,2020-06-30,28 Days,Observational [Patient Registry],FRENCH CORONA,,French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study,French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management: the FRENCH CORONA Study,Recruiting,NA,NA,220,Anticipated,Centre Hospitalier Universitaire de NÄ«mes,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-01T09:24:57Z,2020-05-01T09:24:57Z,5181437,NCT04340466,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-26,NA,NA,2020-03-30,2020-03-26,2020-03-30,Actual,NA,NA,NA,NA,NA,NA,2020-03-30,2020-03-31,Actual,"March 25, 2020",Actual,2020-03-25,March 2020,2020-03-31,"December 31, 2021",Anticipated,2021-12-31,"November 1, 2021",Anticipated,2021-11-01,NA,Interventional,GARM-COVID19,,Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection,Use of cSVF For Residual Lung Damage (COPD/Fibrotic Lung Disease After Symptomatic COVID-19 Infection For Residual Pulmonary Injury or Post-Adult Respiratory Distress Syndrome Following Viral (SARS-Co-2) Infection,Enrolling by invitation,NA,Early Phase 1,10,Anticipated,Healeon Medical Inc,,5,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,No,In discussion phase,2020-05-01T09:26:50Z,2020-05-01T09:26:50Z,5183166,NCT04326036,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-19,NA,NA,2020-04-15,2020-03-19,2020-03-23,Actual,NA,NA,NA,NA,NA,NA,2020-04-15,2020-04-17,Actual,"April 14, 2020",Actual,2020-04-14,April 2020,2020-04-30,"March 31, 2021",Anticipated,2021-03-31,"December 31, 2020",Anticipated,2020-12-31,NA,Interventional,PHYDRA,,Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial),Chemoprophylaxis With Hydroxychloroquine in Healthcare Personnel in Contact With COVID-19 Patients: A Randomized Controlled Trial (PHYDRA Trial),Recruiting,NA,Phase 3,400,Anticipated,"National Institute of Respiratory Diseases, Mexico",,4,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-01T09:27:55Z,2020-05-01T09:27:55Z,5184257,NCT04318015,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-13,NA,NA,2020-03-30,2020-03-18,2020-03-20,Actual,NA,NA,NA,NA,NA,NA,2020-03-30,2020-04-03,Actual,"March 25, 2020",Actual,2020-03-25,March 2020,2020-03-31,"March 3, 2025",Anticipated,2025-03-03,"April 1, 2021",Anticipated,2021-04-01,NA,Interventional,NO COVID-19,,Norwegian Coronavirus Disease 2019 Study,Norwegian Coronavirus Disease 2019 Study: An Open Labeled Randomized Controlled Pragmatic Trial to Evaluate the Antiviral Effect of Chloroquine in Adult Patients With SARS-CoV-2 Infection,Recruiting,NA,Phase 4,202,Anticipated,"University Hospital, Akershus",,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,NA,NA,2020-05-01T09:28:09Z,2020-05-01T09:28:09Z,5184455,NCT04316377,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-08,NA,NA,2020-03-16,2020-03-11,2020-03-12,Actual,NA,NA,NA,NA,NA,NA,2020-03-16,2020-03-17,Actual,"March 8, 2020",Actual,2020-03-08,March 2020,2020-03-31,"May 31, 2020",Anticipated,2020-05-31,"May 31, 2020",Anticipated,2020-05-31,NA,Observational,NA,,Social Media Use During COVID-19,Getting it Right: Towards Responsible Social Media Use During a Pandemic,Recruiting,NA,NA,5000,Anticipated,Yale-NUS College,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,"Due to stipulations by the Institutional Review Board, data cannot be shared.",2020-05-01T09:29:32Z,2020-05-01T09:29:32Z,5185860,NCT04305574,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-01-26,NA,NA,2020-04-09,2020-01-26,2020-01-29,Actual,NA,NA,NA,NA,NA,NA,2020-04-09,2020-04-10,Actual,"January 1, 2020",Actual,2020-01-01,April 2020,2020-04-30,"December 31, 2020",Anticipated,2020-12-31,"December 31, 2020",Anticipated,2020-12-31,NA,Observational,NA,,"Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV","Development of a Simple, Fast and Portable Recombinase Aided Amplification (RAA) Assay for 2019-nCoV",Recruiting,NA,NA,50,Anticipated,Beijing Ditan Hospital,,NA,1,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-01T09:38:41Z,2020-05-01T09:38:41Z,5193301,NCT04245631,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 13, 2020",2020-05-06,NA,NA,2020-05-07,2020-05-07,2020-05-11,Actual,NA,NA,NA,NA,NA,NA,2020-05-07,2020-05-11,Actual,"May 1, 2020",Actual,2020-05-01,May 2020,2020-05-31,January 2021,Anticipated,2021-01-31,January 2021,Anticipated,2021-01-31,NA,Interventional,CÃ³rdobaTrail,,Inhaled Ibuprofen to Treat COVID-19,"Extended Compassionate Use Program (UCA) With Inhalational Ibuprofen in Patients With Acute Respiratory Pathology, Mediated by COVID-19.",Enrolling by invitation,NA,N/A,40,Actual,QuÃ­mica Luar SRL,,1,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Yes,NA,2020-05-14T08:53:25Z,2020-05-14T08:53:25Z,5902072,NCT04382768,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 13, 2020",2020-05-06,NA,NA,2020-05-06,2020-05-06,2020-05-11,Actual,NA,NA,NA,NA,NA,NA,2020-05-06,2020-05-11,Actual,"March 22, 2020",Actual,2020-03-22,March 2020,2020-03-31,"March 21, 2021",Anticipated,2021-03-21,"March 21, 2021",Anticipated,2021-03-21,NA,Observational,ImmunoCOVID,,Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.,Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.,Enrolling by invitation,NA,NA,1500,Anticipated,University Hospital Southampton NHS Foundation Trust,,NA,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-14T08:53:37Z,2020-05-14T08:53:37Z,5902093,NCT04382508,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 13, 2020",2020-05-07,NA,NA,2020-05-07,2020-05-07,2020-05-11,Actual,NA,NA,NA,NA,NA,NA,2020-05-07,2020-05-11,Actual,"March 19, 2020",Actual,2020-03-19,May 2020,2020-05-31,June 2021,Anticipated,2021-06-30,December 2020,Anticipated,2020-12-31,NA,Interventional,RECOVERY,,Randomized Evaluation of COVID-19 Therapy,Randomized Evaluation of COVID-19 Therapy,Recruiting,NA,Phase 2/Phase 3,12000,Anticipated,University of Oxford,,6,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,FALSE,NA,,NA,Proposals for substudies must be approved by the Steering Committee. Procedures for accessing the data for this study are available on https://www.ndph.ox.ac.uk/data-access,https://www.ndph.ox.ac.uk/data-access,Yes,The data-sharing plans for this study will be made available at a later date.,2020-05-14T08:54:00Z,2020-05-14T08:54:00Z,5902155,NCT04381936,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 13, 2020",2020-05-04,NA,NA,2020-05-08,2020-05-08,2020-05-11,Actual,NA,NA,NA,NA,NA,NA,2020-05-08,2020-05-11,Actual,"March 2, 2020",Actual,2020-03-02,May 2020,2020-05-31,"December 31, 2023",Anticipated,2023-12-31,"February 28, 2022",Anticipated,2022-02-28,NA,Observational,NA,,"Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19","Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of Inpatients During the COVID-19 Outbreak: A Prospective Cohort Study",Recruiting,NA,NA,1000,Anticipated,Oslo University Hospital,,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Respiratory secretions, blood, urine, stool, cerebrospinal fluid
    ",NA,NA,NA,Undecided,NA,2020-05-14T08:54:04Z,2020-05-14T08:54:04Z,5902174,NCT04381819,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 13, 2020",2020-03-23,NA,NA,2020-05-07,2020-03-24,2020-03-26,Actual,NA,NA,NA,NA,NA,NA,2020-05-07,2020-05-11,Actual,"April 6, 2020",Actual,2020-04-06,May 2020,2020-05-31,"March 31, 2021",Anticipated,2021-03-31,"October 31, 2020",Anticipated,2020-10-31,NA,Interventional,ProPAC-COVID,,Proactive Prophylaxis With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19,"Proactive Prophylaxis With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID: A Randomized, Placebo-controlled Double-blinded Trial Evaluating Treatment With Azithromycin and Hydroxychloroquine to Patients With COVID-19",Recruiting,NA,Phase 2,226,Anticipated,"Chronic Obstructive Pulmonary Disease Trial Network, Denmark",,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,NA,NA,2020-05-14T08:56:08Z,2020-05-14T08:56:08Z,5902571,NCT04322396,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 13, 2020",2020-03-13,NA,NA,2020-05-07,2020-03-13,2020-03-17,Actual,NA,NA,NA,NA,NA,NA,2020-05-07,2020-05-11,Actual,"April 13, 2020",Actual,2020-04-13,May 2020,2020-05-31,"April 1, 2021",Anticipated,2021-04-01,"April 1, 2021",Anticipated,2021-04-01,NA,Interventional,NA,,Losartan for Patients With COVID-19 Requiring Hospitalization,Randomized Controlled Trial of Losartan for Patients With COVID-19 Requiring Hospitalization,Recruiting,NA,Phase 2,200,Anticipated,University of Minnesota,,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,No,NA,2020-05-14T08:56:18Z,2020-05-14T08:56:18Z,5902616,NCT04312009,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-05-07,NA,NA,2020-05-07,2020-05-07,2020-05-08,Actual,NA,NA,NA,NA,NA,NA,2020-05-07,2020-05-08,Actual,"May 6, 2020",Actual,2020-05-06,May 2020,2020-05-31,April 2021,Anticipated,2021-04-30,April 2021,Anticipated,2021-04-30,NA,Interventional,ROCO,,ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation,Randomized Controlled Trial (RCT) to Evaluate the Efficacy of an Internet-based Self-help Program for People With Psychological Distress Due to Covid-19,Recruiting,NA,N/A,80,Anticipated,University of Bern,,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-12T09:11:01Z,2020-05-12T09:11:01Z,5887286,NCT04380909,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-05-05,NA,NA,2020-05-06,2020-05-06,2020-05-08,Actual,NA,NA,NA,NA,NA,NA,2020-05-06,2020-05-08,Actual,"April 11, 2020",Actual,2020-04-11,May 2020,2020-05-31,"April 11, 2025",Anticipated,2025-04-11,"April 11, 2021",Anticipated,2021-04-11,NA,Observational,NA,,Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19,"Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19: A Descriptive, Longitudinal, Pragmatic Cohort Study",Recruiting,NA,NA,500,Anticipated,Center for Integrated Care,,NA,1,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,Start with publication for a year.,Site Principal Investigator to review written requests from HIPPA-trained investigators.,NA,Yes,"Confidential, de-identified,demographic and health symptoms will be collected as part of this study.",2020-05-12T09:11:02Z,2020-05-12T09:11:02Z,5887290,NCT04380870,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-27,NA,NA,2020-04-29,2020-04-29,2020-04-30,Actual,NA,NA,NA,NA,NA,NA,2020-04-29,2020-05-01,Actual,"April 27, 2020",Actual,2020-04-27,April 2020,2020-04-30,"December 27, 2020",Anticipated,2020-12-27,"August 27, 2020",Anticipated,2020-08-27,NA,Interventional,NA,,"A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic","A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic",Recruiting,NA,Phase 2,200,Anticipated,Medical University of Vienna,,2,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-12T09:18:43Z,2020-05-12T09:18:43Z,5888501,NCT04369365,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-22,NA,NA,2020-05-05,2020-04-24,2020-04-28,Actual,NA,NA,NA,NA,NA,NA,2020-05-05,2020-05-07,Actual,"April 17, 2020",Actual,2020-04-17,May 2020,2020-05-31,"April 30, 2023",Anticipated,2023-04-30,"January 31, 2023",Anticipated,2023-01-31,NA,Interventional,NA,,Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients,Convalescent Plasma to Limit Coronavirus Associated Complications: a Randomized Blinded Phase 2 Study Comparing the Efficacy and Safety of Anti-SARS-CoV2 Plasma to Placebo in COVID-19 Hospitalized Patients,Recruiting,NA,Phase 2,300,Anticipated,NYU Langone Health,,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,NA,NA,,Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.,"The investigator who proposed to use the data will have access to the data upon reasonable request. Requests should be directed to Mila.Ortigoza@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.",NA,Yes,"IPD that underlie the results reported in this article, after deidenficiation (text, tables, figures, and appendices) will be shared.",2020-05-12T09:19:11Z,2020-05-12T09:19:11Z,5888604,NCT04364737,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-14,NA,NA,2020-05-06,2020-04-14,2020-04-16,Actual,NA,NA,NA,NA,NA,NA,2020-05-06,2020-05-08,Actual,"April 17, 2020",Actual,2020-04-17,May 2020,2020-05-31,"August 31, 2020",Anticipated,2020-08-31,"August 31, 2020",Anticipated,2020-08-31,NA,Interventional,Coronavirus,,Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection,A Phase 2 Randomized Single-Blind Study to Evaluate the Activity and Safety of Low Dose Oral Selinexor (KPT-330) in Patients With Severe COVID-19 Infection,Recruiting,NA,Phase 2,230,Anticipated,Karyopharm Therapeutics Inc,,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-12T09:20:32Z,2020-05-12T09:20:32Z,5888777,NCT04349098,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-03-30,NA,NA,2020-05-07,2020-04-14,2020-04-16,Actual,NA,NA,NA,NA,NA,NA,2020-05-07,2020-05-08,Actual,"April 20, 2020",Actual,2020-04-20,May 2020,2020-05-31,November 2021,Anticipated,2021-11-30,May 2021,Anticipated,2021-05-31,NA,Interventional,BADAS,,BCG Vaccine for Health Care Workers as Defense Against COVID 19,Bacillus Calmette-Guerin Vaccination as Defense Against SARS-CoV-2: A Randomized Controlled Trial to Protect Health Care Workers by Enhanced Trained Immune Responses,Recruiting,NA,Phase 4,1800,Anticipated,Texas A&M University,,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,No,There is not a plan to make IPD available.,2020-05-12T09:20:32Z,2020-05-12T09:20:32Z,5888781,NCT04348370,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-03-20,NA,NA,2020-05-07,2020-03-26,2020-03-27,Actual,NA,NA,NA,NA,NA,NA,2020-05-07,2020-05-08,Actual,"April 23, 2020",Actual,2020-04-23,March 2020,2020-03-31,May 2021,Anticipated,2021-05-31,May 2021,Anticipated,2021-05-31,NA,Interventional,NA,,A Study of a Candidate COVID-19 Vaccine (COV001),"A Phase I/II Study to Determine Efficacy, Safety and Immunogenicity of the Candidate Coronavirus Disease (COVID-19) Vaccine ChAdOx1 nCoV-19 in UK Healthy Adult Volunteers",Recruiting,NA,Phase 1/Phase 2,1090,Anticipated,University of Oxford,,9,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-12T09:21:36Z,2020-05-12T09:21:36Z,5888970,NCT04324606,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-03-23,NA,NA,2020-05-04,2020-03-23,2020-03-26,Actual,NA,NA,NA,NA,NA,NA,2020-05-04,2020-05-06,Actual,"March 24, 2020",Actual,2020-03-24,May 2020,2020-05-31,"August 30, 2020",Anticipated,2020-08-30,"June 30, 2020",Anticipated,2020-06-30,NA,Observational,B-DT-COV2,,Biomarkers for Identification of COVID-19 Infection,Biomarkers Identification for Diagnosis and Treatment of SARS-COV-2 Infection,Recruiting,NA,NA,110,Anticipated,University of Catanzaro,,NA,2,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-12T09:21:38Z,2020-05-12T09:21:38Z,5888974,NCT04322513,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-03-24,NA,NA,2020-05-04,2020-03-24,2020-03-26,Actual,NA,NA,NA,NA,NA,NA,2020-05-04,2020-05-06,Actual,"April 1, 2020",Actual,2020-04-01,May 2020,2020-05-31,"August 30, 2020",Anticipated,2020-08-30,"August 30, 2020",Anticipated,2020-08-30,NA,Interventional,Coalition-I,,Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19),"An Open-label, Randomized Controlled Trial of Hydroxychloroquine and Azitromicyn for COVID-19 Infection on Hospitalized, Noncritical Patients",Recruiting,NA,Phase 3,630,Anticipated,Hospital do Coracao,,3,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-12T09:21:40Z,2020-05-12T09:21:40Z,5888984,NCT04322123,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-03-13,NA,NA,2020-04-29,2020-03-13,2020-03-17,Actual,NA,NA,NA,NA,NA,NA,2020-04-29,2020-05-04,Actual,"April 9, 2020",Actual,2020-04-09,April 2020,2020-04-30,"April 1, 2021",Anticipated,2021-04-01,"April 1, 2021",Anticipated,2021-04-01,NA,Interventional,NA,,Losartan for Patients With COVID-19 Not Requiring Hospitalization,Randomized Controlled Trial of Losartan for Patients With COVID-19 Not Requiring Hospitalization,Recruiting,NA,Phase 2,580,Anticipated,University of Minnesota,,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,No,NA,2020-05-12T09:21:56Z,2020-05-12T09:21:56Z,5889061,NCT04311177,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-02-14,NA,NA,2020-04-29,2020-02-14,2020-02-18,Actual,NA,NA,NA,NA,NA,NA,2020-04-29,2020-05-01,Actual,"February 16, 2020",Actual,2020-02-16,April 2020,2020-04-30,"June 1, 2020",Anticipated,2020-06-01,"May 10, 2020",Anticipated,2020-05-10,NA,Interventional,NA,,Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19),Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19),"Active, not recruiting",NA,N/A,18,Actual,Second Affiliated Hospital of Wenzhou Medical University,,2,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-12T09:22:56Z,2020-05-12T09:22:56Z,5889333,NCT04273763,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-05-14,NA,NA,2020-05-14,2020-05-14,2020-05-15,Estimate,NA,NA,NA,NA,NA,NA,2020-05-14,2020-05-15,Estimate,"March 24, 2020",Actual,2020-03-24,May 2020,2020-05-31,"May 30, 2020",Anticipated,2020-05-30,"May 4, 2020",Actual,2020-05-04,NA,Observational,NA,,Respiratory Decompensation and Model for the Triage of COVID-19 Patients,Respiratory Decompensation and Model for the Triage of COVID-19 Patients: a Prospective Study,"Active, not recruiting",NA,NA,197,Actual,Dascena,,NA,1,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-18T06:28:58Z,2020-05-18T06:28:58Z,5906736,NCT04390516,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-05-07,NA,NA,2020-05-14,2020-05-14,2020-05-15,Estimate,NA,NA,NA,NA,NA,NA,2020-05-14,2020-05-15,Estimate,"May 4, 2020",Actual,2020-05-04,May 2020,2020-05-31,May 2021,Anticipated,2021-05-31,July 2020,Anticipated,2020-07-31,NA,Interventional,NA,,Study to Evaluate the Effect of a Probiotic in COVID-19,The Intestinal Microbiota as a Therapeutic Target in Hospitalized Patients With COVID-19 Infection,Recruiting,NA,N/A,40,Anticipated,Bioithas SL,,2,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-18T06:29:00Z,2020-05-18T06:29:00Z,5906740,NCT04390477,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-05-13,NA,NA,2020-05-14,2020-05-14,2020-05-15,Estimate,NA,NA,NA,NA,NA,NA,2020-05-14,2020-05-15,Estimate,"May 4, 2020",Actual,2020-05-04,May 2020,2020-05-31,December 2020,Anticipated,2020-12-31,August 2020,Anticipated,2020-08-31,NA,Interventional,NA,,Low Dose Radiotherapy in COVID-19 Pneumonia,Assessment of Adding Low Dose Pulmonary Radiotherapy to the National Protocol of COVID-19 Management: A Pilot Trial,Recruiting,NA,Phase 1/Phase 2,5,Anticipated,Shahid Beheshti University of Medical Sciences,,1,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,After the completion of trial for one year.,Verified researchers,NA,Yes,IPD will be shared after the completion of study to other researchers.,2020-05-18T06:29:02Z,2020-05-18T06:29:02Z,5906747,NCT04390412,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-05-12,NA,NA,2020-05-13,2020-05-13,2020-05-15,Estimate,NA,NA,NA,NA,NA,NA,2020-05-13,2020-05-15,Estimate,"May 7, 2020",Actual,2020-05-07,May 2020,2020-05-31,May 2021,Anticipated,2021-05-31,April 2021,Anticipated,2021-04-30,NA,Interventional,PAP-COVID,,Early CPAP in COVID-19 Confirmed or Suspected Patients,Early Continuous Positive Airway Pressure (CPAP) in COVID-19 Confirmed or Suspected Patients,Recruiting,NA,N/A,200,Anticipated,Icahn School of Medicine at Mount Sinai,,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,TRUE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-18T06:29:09Z,2020-05-18T06:29:09Z,5906775,NCT04390191,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-04-10,NA,NA,2020-05-13,2020-05-13,2020-05-15,Estimate,NA,NA,NA,NA,NA,NA,2020-05-13,2020-05-15,Estimate,"April 10, 2020",Actual,2020-04-10,May 2020,2020-05-31,December 2020,Anticipated,2020-12-31,June 2020,Anticipated,2020-06-30,NA,Interventional,NA,,Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19),Plasma From Individuals Who Have Recovered From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection as Treatment for Acute COVID-19 Disease,"Active, not recruiting",NA,Phase 1/Phase 2,10,Actual,Karolinska University Hospital,,1,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Yes,We will be sharing data but data the management plan is being designed.,2020-05-18T06:29:10Z,2020-05-18T06:29:10Z,5906776,NCT04390178,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 06, 2020",2020-04-20,NA,NA,2020-04-23,2020-04-21,2020-04-22,Actual,NA,NA,NA,NA,NA,NA,2020-04-23,2020-04-27,Actual,"April 15, 2020",Actual,2020-04-15,April 2020,2020-04-30,"April 15, 2022",Anticipated,2022-04-15,"April 15, 2022",Anticipated,2022-04-15,NA,Interventional,SAVE,,suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE),"suPAR-guided Anakinra Treatment for Validation of the Risk and Early Management of Severe Respiratory Failure by COVID-19: The SAVE Open-label, Non-randomized Single-arm Trial",Recruiting,NA,Phase 2,100,Anticipated,Hellenic Institute for the Study of Sepsis,,1,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-07T09:14:05Z,2020-05-07T09:14:05Z,5807739,NCT04357366,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 06, 2020",2020-03-29,NA,NA,2020-04-23,2020-04-01,2020-04-03,Actual,NA,NA,NA,NA,NA,NA,2020-04-23,2020-04-27,Actual,"April 6, 2020",Actual,2020-04-06,March 2020,2020-03-31,"July 31, 2021",Anticipated,2021-07-31,"August 31, 2020",Anticipated,2020-08-31,NA,Interventional,STROMA-CoV2,,Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS,Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS,Recruiting,NA,Phase 1/Phase 2,60,Anticipated,Assistance Publique - HÃ´pitaux de Paris,,2,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-07T09:15:47Z,2020-05-07T09:15:47Z,5808033,NCT04333368,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-05-12,NA,NA,2020-05-14,2020-05-14,2020-05-15,Estimate,NA,NA,NA,NA,NA,NA,2020-05-14,2020-05-15,Estimate,"March 31, 2020",Actual,2020-03-31,May 2020,2020-05-31,"June 30, 2020",Anticipated,2020-06-30,"June 30, 2020",Anticipated,2020-06-30,NA,Interventional,NA,,Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19,Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe Coronavirus Disease 2019 Infectious Disease (COVID-19),Recruiting,NA,N/A,15,Anticipated,"University Hospital, Basel, Switzerland",,1,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-18T06:29:21Z,2020-05-18T06:29:21Z,5906815,NCT04389944,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-04-12,NA,NA,2020-04-16,2020-04-16,2020-04-21,Actual,NA,NA,NA,NA,NA,NA,2020-04-16,2020-04-21,Actual,"March 31, 2020",Actual,2020-03-31,April 2020,2020-04-30,"May 31, 2020",Anticipated,2020-05-31,"May 1, 2020",Anticipated,2020-05-01,NA,Observational,TARUS,,The Ariel University Survey on Dietary Changes and Anxiety During the Coronavirus Pandemic,The Ariel University Survey on Dietary Changes and Anxiety During the Coronavirus Pandemic: TARUS,Recruiting,NA,NA,3000,Anticipated,Ariel University,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-01T09:23:15Z,2020-05-01T09:23:15Z,5179992,NCT04353934,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-04-09,NA,NA,2020-04-21,2020-04-15,2020-04-20,Actual,NA,NA,NA,NA,NA,NA,2020-04-21,2020-04-24,Actual,"April 7, 2020",Actual,2020-04-07,April 2020,2020-04-30,"June 15, 2021",Anticipated,2021-06-15,April 2021,Anticipated,2021-04-30,NA,Interventional,NA,,PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine,PATCH 2 & 3: (Prevention and Treatment of COVID-19 With Hydroxychloroquine) An Open Label Multi-arm Randomized Trial of Hydroxychloroquine in the Prevention and Treatment of COVID-19,Recruiting,NA,Phase 2,850,Anticipated,UnitedHealth Group,,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,FALSE,NA,,1 year,NA,NA,Yes,Data will be collected and managed by Optumcare and UnitedHealth Group Research & Development. Redacted/aggregate data will be shared with the University Of Penn using approved data sharing protocols.,2020-05-04T09:04:29Z,2020-05-04T09:04:29Z,5776713,NCT04353037,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-04-08,NA,NA,2020-04-13,2020-04-08,2020-04-13,Actual,NA,NA,NA,NA,NA,NA,2020-04-13,2020-04-15,Actual,"April 10, 2020",Anticipated,2020-04-10,April 2020,2020-04-30,"July 1, 2020",Anticipated,2020-07-01,"June 1, 2020",Anticipated,2020-06-01,NA,Interventional,STOP COVID,,"A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection","A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection",Recruiting,NA,Phase 2,152,Anticipated,Washington University School of Medicine,,2,NA,NA,FALSE,NA,NA,NA,FALSE,TRUE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,NA,NA,2020-05-01T09:24:40Z,2020-05-01T09:24:40Z,5181187,NCT04342663,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-04-04,NA,NA,2020-04-10,2020-04-08,2020-04-13,Actual,NA,NA,NA,NA,NA,NA,2020-04-10,2020-04-14,Actual,"April 8, 2020",Actual,2020-04-08,April 2020,2020-04-30,September 2020,Anticipated,2020-09-30,September 2020,Anticipated,2020-09-30,NA,Interventional,CloroCOVID19II,,Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection,"Phase IIb Study to Evaluate the Efficacy and Safety of Chloroquine Diphosphate in the Treatment of Patients With Comorbidities, Without Severe Acute Respiratory Syndrome, Under the New Coronavirus (SARS-CoV2): a Double-blind, Randomized, Placebo-controlled Clinical Trial",Recruiting,NA,Phase 2,210,Anticipated,FundaÃ§Ã£o de Medicina Tropical Dr. Heitor Vieira Dourado,,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,after study publication,Upon formal request to researchers.,NA,Yes,all patient data will be shared after study publication,2020-05-01T09:24:40Z,2020-05-01T09:24:40Z,5181190,NCT04342650,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-04-07,NA,NA,2020-04-22,2020-04-07,2020-04-10,Actual,NA,NA,NA,NA,NA,NA,2020-04-22,2020-04-24,Actual,"April 6, 2020",Actual,2020-04-06,April 2020,2020-04-30,"December 30, 2020",Anticipated,2020-12-30,"August 30, 2020",Anticipated,2020-08-30,NA,Interventional,NA,,Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19,Treatment With Hydroxychloroquine vs Nitazoxanide + Hydroxychloroquine in Patients With COVID-19 With Risk Factors for Poor Outcome,Recruiting,NA,Phase 4,86,Anticipated,Materno-Perinatal Hospital of the State of Mexico,,2,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,After finishing the study.,Requested by the journal or after publication if any researcher in the world express interest if the information of this survey.,NA,Yes,"If the final selected medical journal to send the paper of our research request it, we will add the full database of the studied population.",2020-05-04T09:05:26Z,2020-05-04T09:05:26Z,5776837,NCT04341493,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-04-01,NA,NA,2020-04-22,2020-04-07,2020-04-08,Actual,NA,NA,NA,NA,NA,NA,2020-04-22,2020-04-24,Actual,"March 31, 2020",Actual,2020-03-31,April 2020,2020-04-30,"December 31, 2020",Anticipated,2020-12-31,"December 31, 2020",Anticipated,2020-12-31,NA,Interventional,REPLACECOVID,,Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019,The Randomized Elimination or Prolongation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Coronavirus Disease 2019,Enrolling by invitation,NA,N/A,152,Anticipated,University of Pennsylvania,,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,Not making it available,2020-05-04T09:05:38Z,2020-05-04T09:05:38Z,5776874,NCT04338009,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-04-08,NA,NA,2020-04-10,2020-04-08,2020-04-10,Actual,NA,NA,NA,NA,NA,NA,2020-04-10,2020-04-13,Actual,"March 25, 2020",Actual,2020-03-25,April 2020,2020-04-30,March 2021,Anticipated,2021-03-31,March 2021,Anticipated,2021-03-31,NA,Observational,NA,,Acquiring Convalescent Specimens for COVID-19 Antibodies,Acquiring Convalescent Specimens to Isolate and Identify Potent Monoclonal Antibodies Against COVID-19,Recruiting,NA,NA,12,Anticipated,Columbia University,,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Whole blood from which peripheral blood mononuclear cells (PBMCs) and plasma will be
      processed.
    ",NA,NA,NA,NA,NA,2020-05-01T09:24:43Z,2020-05-01T09:24:43Z,5181244,NCT04342195,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-03-24,NA,NA,2020-04-22,2020-03-24,2020-03-27,Actual,NA,NA,NA,NA,NA,NA,2020-04-22,2020-04-24,Actual,"March 20, 2020",Actual,2020-03-20,April 2020,2020-04-30,"March 31, 2024",Anticipated,2024-03-31,"March 31, 2024",Anticipated,2024-03-31,12 Months,Observational [Patient Registry],PRIORITY,,COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY),PRIORITY (Pregnancy Coronavirus Outcomes Registry),Recruiting,NA,NA,2000,Anticipated,"University of California, San Francisco",,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-04T09:06:23Z,2020-05-04T09:06:23Z,5777035,NCT04323839,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-03-23,NA,NA,2020-04-22,2020-03-25,2020-03-26,Actual,NA,NA,NA,NA,NA,NA,2020-04-22,2020-04-24,Actual,"March 23, 2020",Actual,2020-03-23,April 2020,2020-04-30,September 2020,Anticipated,2020-09-30,September 2020,Anticipated,2020-09-30,NA,Interventional,COVID-19,,Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA),Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA),Recruiting,NA,Phase 3,6000,Anticipated,Montreal Heart Institute,,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,NA,NA,2020-05-04T09:06:26Z,2020-05-04T09:06:26Z,5777048,NCT04322682,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-03-24,NA,NA,2020-04-22,2020-03-24,2020-03-26,Actual,NA,NA,NA,NA,NA,NA,2020-04-22,2020-04-24,Actual,"April 17, 2020",Actual,2020-04-17,April 2020,2020-04-30,July 2021,Anticipated,2021-07-31,February 2021,Anticipated,2021-02-28,NA,Interventional,NA,,Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients,Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients,Enrolling by invitation,NA,Phase 2,1000,Anticipated,Nova Scotia Health Authority,,4,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-04T09:06:30Z,2020-05-04T09:06:30Z,5777063,NCT04321993,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-04-06,NA,NA,2020-04-06,2020-04-06,2020-04-09,Actual,NA,NA,NA,NA,NA,NA,2020-04-06,2020-04-09,Actual,"March 1, 2020",Actual,2020-03-01,April 2020,2020-04-30,"April 15, 2020",Anticipated,2020-04-15,"April 15, 2020",Anticipated,2020-04-15,NA,Observational,NA,,COVID-19 Risk Stratification,COVID-19 Risk Stratification,Recruiting,NA,NA,1500,Anticipated,Brigham and Women's Hospital,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,Investigators may provide reasonable requests for IPD. These requests will be reviewed by the study team and institution on a case by case basis.,2020-05-01T09:25:06Z,2020-05-01T09:25:06Z,5181566,NCT04339387,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-04-06,NA,NA,2020-04-06,2020-04-06,2020-04-07,Actual,NA,NA,NA,NA,NA,NA,2020-04-06,2020-04-07,Actual,"December 23, 2019",Actual,2019-12-23,March 2020,2020-03-31,"March 3, 2020",Actual,2020-03-03,"January 20, 2020",Actual,2020-01-20,NA,Observational,NA,,Clinical and Radiomic Model of COVID-19,A Clinical and Radiological Model to Predict the Prognosis for COVID-19 Patients,Completed,NA,NA,300,Actual,Maastricht University,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,No share plan,2020-05-01T09:25:20Z,2020-05-01T09:25:20Z,5181778,NCT04337502,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-26,NA,NA,2020-04-13,2020-03-27,2020-03-31,Actual,NA,NA,NA,NA,NA,NA,2020-04-13,2020-04-15,Actual,"April 13, 2020",Actual,2020-04-13,April 2020,2020-04-30,"August 30, 2020",Anticipated,2020-08-30,"August 30, 2020",Anticipated,2020-08-30,NA,Interventional,CoDEX,,COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III,"COVID-19-associated ARDS Treated With DEXamethasone: an Open-label, Randomized, Controlled Trial: CoDEX (Alliance Covid-19 Brasil III)",Recruiting,NA,Phase 3,290,Anticipated,Hospital Sirio-Libanes,,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,No,NA,2020-05-01T09:26:39Z,2020-05-01T09:26:39Z,5182985,NCT04327401,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-24,NA,NA,2020-03-30,2020-03-30,2020-03-31,Actual,NA,NA,NA,NA,NA,NA,2020-03-30,2020-03-31,Actual,"March 28, 2020",Anticipated,2020-03-28,March 2020,2020-03-31,"September 30, 2020",Anticipated,2020-09-30,"May 20, 2020",Anticipated,2020-05-20,NA,Interventional,NA,,Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial,Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial,Enrolling by invitation,NA,N/A,30,Anticipated,Mazandaran University of Medical Sciences,,1,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-01T09:26:40Z,2020-05-01T09:26:40Z,5182997,NCT04327349,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-25,NA,NA,2020-03-30,2020-03-27,2020-03-30,Actual,NA,NA,NA,NA,NA,NA,2020-03-30,2020-04-01,Actual,"March 27, 2020",Anticipated,2020-03-27,March 2020,2020-03-31,"June 1, 2020",Anticipated,2020-06-01,"May 1, 2020",Anticipated,2020-05-01,NA,Interventional,NA,,Treating COVID-19 With a Bidirectional Oxygenation Valve,The Use of a Bidirectional Oxygenation Valve in the Management of Respiratory Failure Due to COVID-19 Infection,Recruiting,NA,N/A,15,Anticipated,TMC HealthCare,,1,NA,NA,FALSE,NA,NA,NA,NA,FALSE,TRUE,TRUE,NA,FALSE,NA,,NA,NA,NA,NA,NA,2020-05-01T09:26:47Z,2020-05-01T09:26:47Z,5183099,NCT04326452,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-23,NA,NA,2020-03-25,2020-03-23,2020-03-26,Actual,NA,NA,NA,NA,NA,NA,2020-03-25,2020-03-27,Actual,"March 23, 2020",Actual,2020-03-23,March 2020,2020-03-31,"August 30, 2020",Anticipated,2020-08-30,"June 30, 2020",Anticipated,2020-06-30,NA,Interventional,add-on-COV2,,Escin in Patients With Covid-19 Infection,Efficacy and Safety of Escin as add-on Treatment in Covid-19 Infected Patients,Recruiting,NA,Phase 2/Phase 3,120,Anticipated,University of Catanzaro,,3,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,NA,NA,2020-05-01T09:27:23Z,2020-05-01T09:27:23Z,5183692,NCT04322344,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-23,NA,NA,2020-03-30,2020-03-24,2020-03-25,Actual,NA,NA,NA,NA,NA,NA,2020-03-30,2020-04-02,Actual,"March 21, 2020",Actual,2020-03-21,March 2020,2020-03-31,"March 20, 2022",Anticipated,2022-03-20,"March 20, 2021",Anticipated,2021-03-20,1 Year,Observational [Patient Registry],BEAT19,,"Behavior, Environment And Treatments for Covid-19",A PATIENT-CENTRIC OUTCOMES REGISTRY OF PATIENTS WITH KNOWN OR SUSPECTED NOVEL CORONAVIRUS INFECTION SARS-COV-2 (COVID-19),Recruiting,NA,NA,100000,Anticipated,xCures,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,De-identified datasets will be made available to qualified researchers in accordance with the study protocol.,2020-05-01T09:27:26Z,2020-05-01T09:27:26Z,5183762,NCT04321811,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-18,NA,NA,2020-04-17,2020-03-23,2020-03-25,Actual,NA,NA,NA,NA,NA,NA,2020-04-17,2020-04-21,Actual,"April 17, 2020",Actual,2020-04-17,April 2020,2020-04-30,"March 31, 2022",Anticipated,2022-03-31,"March 31, 2021",Anticipated,2021-03-31,NA,Interventional,CORIPREV-LR,,COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir,COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir,Recruiting,NA,Phase 3,1220,Anticipated,"St. Michael's Hospital, Toronto",,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,TRUE,NA,,NA,NA,NA,Undecided,TBA,2020-05-01T09:27:30Z,2020-05-01T09:27:30Z,5183840,NCT04321174,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-23,NA,NA,2020-03-27,2020-03-23,2020-03-25,Actual,NA,NA,NA,NA,NA,NA,2020-03-27,2020-03-31,Actual,"March 27, 2020",Actual,2020-03-27,March 2020,2020-03-31,"March 20, 2030",Anticipated,2030-03-20,"March 27, 2022",Anticipated,2022-03-27,NA,Observational,NA,,Risk Factors for Community- and Workplace Transmission of COVID-19,Risk Factors for Community- and Workplace Transmission of COVID-19,Recruiting,NA,NA,50000,Anticipated,Oslo University Hospital,,NA,5,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Blood and upper repiratory samples will be collected from some participants.
    ",NA,NA,NA,No,"European GDPR regulations severely limits IPD, but the study will share data to the largest extent possible within GDPR.",2020-05-01T09:27:34Z,2020-05-01T09:27:34Z,5183921,NCT04320732,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-20,NA,NA,2020-03-22,2020-03-22,2020-03-24,Actual,NA,NA,NA,NA,NA,NA,2020-03-22,2020-03-24,Actual,"March 5, 2020",Actual,2020-03-05,March 2020,2020-03-31,"June 25, 2020",Anticipated,2020-06-25,"April 30, 2020",Anticipated,2020-04-30,NA,Interventional,NA,,Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia,Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia,Recruiting,NA,Phase 2/Phase 3,150,Anticipated,Beijing Chao Yang Hospital,,3,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-01T09:27:40Z,2020-05-01T09:27:40Z,5184016,NCT04319900,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-19,NA,NA,2020-03-30,2020-03-23,2020-03-24,Actual,NA,NA,NA,NA,NA,NA,2020-03-30,2020-03-31,Actual,"March 19, 2020",Actual,2020-03-19,March 2020,2020-03-31,"March 19, 2022",Anticipated,2022-03-19,"March 19, 2022",Anticipated,2022-03-19,NA,Observational,COVID-BioB,,"COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor","Study to Characterize Patients With SARS-Cov-2 Infection and to Create a Biobank to Identify Predictors of Disease Severity, Mortality and Treatment Response",Recruiting,NA,NA,1000,Anticipated,UniversitÃ  Vita-Salute San Raffaele,,NA,1,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-01T09:27:50Z,2020-05-01T09:27:50Z,5184210,NCT04318366,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-17,NA,NA,2020-03-25,2020-03-19,2020-03-23,Actual,NA,NA,NA,NA,NA,NA,2020-03-25,2020-03-26,Actual,"March 18, 2020",Actual,2020-03-18,March 2020,2020-03-31,"December 31, 2021",Anticipated,2021-12-31,"December 31, 2020",Anticipated,2020-12-31,6 Months,Observational [Patient Registry],COVID19-HCW,,COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2,COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2,Recruiting,NA,NA,400,Anticipated,"University College, London",,NA,1,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Blood samples Nasal and oropharygeal swabs
    ",NA,NA,NA,Yes,Publication of results in open access journals; sharing of results in scientific databases.,2020-05-01T09:27:51Z,2020-05-01T09:27:51Z,5184216,NCT04318314,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-18,NA,NA,2020-04-15,2020-03-18,2020-03-20,Actual,NA,NA,NA,NA,NA,NA,2020-04-15,2020-04-17,Actual,"April 14, 2020",Actual,2020-04-14,April 2020,2020-04-30,"March 22, 2021",Anticipated,2021-03-22,"October 31, 2020",Anticipated,2020-10-31,NA,Interventional,HYDRA,,Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial),Hydroxychloroquine Treatment for Severe COVID-19 Respiratory Disease: Randomised Clinical Trial (HYDRA Trial),Recruiting,NA,Phase 3,500,Anticipated,"National Institute of Respiratory Diseases, Mexico",,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,Undecided,As requested by other investigators.,2020-05-01T09:28:14Z,2020-05-01T09:28:14Z,5184507,NCT04315896,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-18,NA,NA,2020-03-19,2020-03-19,2020-03-20,Actual,NA,NA,NA,NA,NA,NA,2020-03-19,2020-03-20,Actual,"January 1, 2020",Actual,2020-01-01,March 2020,2020-03-31,"April 30, 2020",Anticipated,2020-04-30,"April 20, 2020",Anticipated,2020-04-20,3 Months,Observational [Patient Registry],I-COVID,,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy.,Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy,Recruiting,NA,NA,20,Anticipated,Federico II University,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,not decided yet,2020-05-01T09:28:14Z,2020-05-01T09:28:14Z,5184514,NCT04315870,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-05-12,NA,NA,2020-05-14,2020-05-14,2020-05-15,Estimate,NA,NA,NA,NA,NA,NA,2020-05-14,2020-05-15,Estimate,"May 1, 2020",Actual,2020-05-01,May 2020,2020-05-31,"May 31, 2021",Anticipated,2021-05-31,"September 30, 2020",Anticipated,2020-09-30,NA,Interventional,NA,,COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo),Aerosol Inhalation of the Exosomes Derived From Allogenic COVID-19 T Cell in the Treatment of Early Stage Novel Coronavirus Pneumonia,"Active, not recruiting",NA,Phase 1,60,Anticipated,TC Erciyes University,,1,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,TRUE,NA,,NA,NA,NA,Undecided,NA,2020-05-18T06:29:42Z,2020-05-18T06:29:42Z,5906871,NCT04389385,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-30,NA,NA,2020-04-09,2020-03-30,2020-04-01,Actual,NA,NA,NA,NA,NA,NA,2020-04-09,2020-04-13,Actual,"March 30, 2020",Actual,2020-03-30,April 2020,2020-04-30,"March 1, 2021",Anticipated,2021-03-01,"January 31, 2021",Anticipated,2021-01-31,NA,Interventional,CORONACION,,Coronavirus (COVID-19) ACEi/ARB Investigation,The CORONAvirus Disease 2019 Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker InvestigatiON (CORONACION) Randomized Clinical Trial,Recruiting,NA,Phase 4,2414,Anticipated,"National University of Ireland, Galway, Ireland",,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,FALSE,NA,,12-24 months,To be determined,NA,Yes,NA,2020-05-01T09:26:19Z,2020-05-01T09:26:19Z,5182642,NCT04330300,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-27,NA,NA,2020-04-08,2020-03-30,2020-03-31,Actual,NA,NA,NA,NA,NA,NA,2020-04-08,2020-04-10,Actual,"April 6, 2020",Actual,2020-04-06,April 2020,2020-04-30,August 2020,Anticipated,2020-08-31,August 2020,Anticipated,2020-08-31,NA,Interventional,NA,,Pre-exposure Prophylaxis for SARS-Coronavirus-2,Pre-exposure Prophylaxis for SARS-Coronavirus-2: A Pragmatic Randomized Clinical Trial,Recruiting,NA,Phase 3,3500,Anticipated,University of Minnesota,,3,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-01T09:26:31Z,2020-05-01T09:26:31Z,5182837,NCT04328467,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-26,NA,NA,2020-04-10,2020-03-26,2020-03-31,Actual,NA,NA,NA,NA,NA,NA,2020-04-10,2020-04-14,Actual,"March 25, 2020",Actual,2020-03-25,April 2020,2020-04-30,"April 10, 2020",Anticipated,2020-04-10,"April 3, 2020",Anticipated,2020-04-03,NA,Observational,NA,,A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research,A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research,Recruiting,NA,NA,120,Anticipated,UnitedHealth Group,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      Patients will return at the following times to complete the same battery of sample
      collection:

        -  7-9 days after initially testing positive;

        -  14-18 days after initially testing positive;

        -  28-42 days after initially testing positive. Additional visits, during which additional
           samples could be collected may occur after 42 days if agreeable to the participants and
           desired by the study investigators.
    ",2 months,"The data collected due to this study will be extracted from the medical record and stored for additional research analysis to demonstrate equivalence between location in the two nasal swabs. Blood samples will be delivered to PATH and the Mayo Clinic for storage and analysis. Patients may not have access to these samples or the blood features derived from them after sample collection. Data will be shared between the participating clinics, UHG and collaborating partners performing the analysis of the samples and returning results.",NA,Yes,"Four data sources will be recorded for each patient who consents to participate in the study:
Electronic medical record (EMR);
Results of testing from the foam and polyester nasal swab samples;
Results of any blood testing performed on the blood samples;
Responses to a set of standard questions posed to each participant.",2020-05-01T09:26:36Z,2020-05-01T09:26:36Z,5182937,NCT04327804,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-24,NA,NA,2020-03-24,2020-03-24,2020-03-26,Actual,NA,NA,NA,NA,NA,NA,2020-03-24,2020-03-26,Actual,"March 9, 2020",Actual,2020-03-09,March 2020,2020-03-31,"May 1, 2020",Anticipated,2020-05-01,"May 1, 2020",Anticipated,2020-05-01,NA,Observational,NA,,Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection (CoV-CONTACT-SERO),Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection,Recruiting,NA,NA,300,Anticipated,"Institut National de la SantÃ© Et de la Recherche MÃ©dicale, France",,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Blood samples
    ",NA,NA,NA,Undecided,NA,2020-05-01T09:27:23Z,2020-05-01T09:27:23Z,5183702,NCT04322279,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-05-12,NA,NA,2020-05-12,2020-05-12,2020-05-14,Actual,NA,NA,NA,NA,NA,NA,2020-05-12,2020-05-14,Actual,"February 20, 2020",Actual,2020-02-20,February 2020,2020-02-29,"May 30, 2020",Anticipated,2020-05-30,"May 20, 2020",Anticipated,2020-05-20,NA,Observational,NA,,Survey of Satisfaction on Traditional Chinese Medicine Jing-Guan-Fang (JGF) for COVID-19 Prevention,"Department of Chinese Medicine, Branch of Linsen, Chinese Medicine, and Kunming, Taipei City Hospital, Taipei, Taiwan Institute of Traditional Medicine, National Yang-Ming University, Taipei, Taiwan.",Recruiting,NA,NA,300,Anticipated,Taipei City Hospital,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-18T06:30:16Z,2020-05-18T06:30:16Z,5906964,NCT04388644,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-05-07,NA,NA,2020-05-13,2020-05-12,2020-05-14,Actual,NA,NA,NA,NA,NA,NA,2020-05-13,2020-05-15,Estimate,"April 21, 2020",Actual,2020-04-21,May 2020,2020-05-31,September 2022,Anticipated,2022-09-30,September 2021,Anticipated,2021-09-30,20 Months,Observational [Patient Registry],ASPIRE,,Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic,Assessing the Safety of Pregnancy In the CoRonavirus pandEmic: a Nationwide Prospective Study,Recruiting,NA,NA,11000,Anticipated,"University of California, San Francisco",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      At-home blood spot kits will be used for serology surveillance. Tests will occur weekly
      during the first trimester and monthly during the second and third trimesters of pregnancy.
      Covid-19 antibody serology and cytokine testing will be assayed using these blood spot cars.
    ",NA,NA,NA,Yes,NA,2020-05-18T06:30:17Z,2020-05-18T06:30:17Z,5906973,NCT04388605,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-05-07,NA,NA,2020-05-07,2020-05-07,2020-05-08,Actual,NA,NA,NA,NA,NA,NA,2020-05-07,2020-05-08,Actual,"April 29, 2020",Actual,2020-04-29,May 2020,2020-05-31,April 2021,Anticipated,2021-04-30,April 2021,Anticipated,2021-04-30,NA,Interventional,NA,,Efficacy and Safety of PolyoxidoniumÂ® in Hospitalized Patients With Coronavirus Disease COVID-19,"A Multi-centre, Adaptive, Randomized, Double-blind, Placebo-controlled Comparative Clinical Study of the Safety and Efficacy of PolyoxidoniumÂ®, Lyophilizate for Solution for Injections and Topical Application, 6 mg (NPO Petrovax Pharm LLC, Russia) in Patients With Coronavirus Disease (COVID-19).",Recruiting,NA,Phase 2/Phase 3,394,Anticipated,NPO Petrovax,,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-12T09:10:44Z,2020-05-12T09:10:44Z,5887228,NCT04381377,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-05-06,NA,NA,2020-05-06,2020-05-06,2020-05-08,Actual,NA,NA,NA,NA,NA,NA,2020-05-06,2020-05-08,Actual,"April 23, 2020",Actual,2020-04-23,May 2020,2020-05-31,"November 15, 2020",Anticipated,2020-11-15,"October 15, 2020",Anticipated,2020-10-15,NA,Interventional,NA,,Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19),"An International, Multicenter, Randomized, Double-blind, Adaptive Placebo-controlled Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe SARS-CoV-2 Infection (COVID-19)",Recruiting,NA,Phase 2/Phase 3,372,Anticipated,R-Pharm,,3,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-12T09:11:15Z,2020-05-12T09:11:15Z,5887328,NCT04380519,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-30,NA,NA,2020-05-04,2020-05-04,2020-05-06,Actual,NA,NA,NA,NA,NA,NA,2020-05-04,2020-05-06,Actual,"April 9, 2020",Actual,2020-04-09,May 2020,2020-05-31,"May 31, 2020",Anticipated,2020-05-31,"May 31, 2020",Anticipated,2020-05-31,NA,Observational,NA,,"COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior","COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior",Recruiting,NA,NA,25000,Anticipated,Milton S. Hershey Medical Center,,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-12T09:13:04Z,2020-05-12T09:13:04Z,5887650,NCT04377581,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-28,NA,NA,2020-05-07,2020-05-05,2020-05-06,Actual,NA,NA,NA,NA,NA,NA,2020-05-07,2020-05-08,Actual,"May 5, 2020",Actual,2020-05-05,May 2020,2020-05-31,"June 5, 2021",Anticipated,2021-06-05,"June 5, 2021",Anticipated,2021-06-05,NA,Interventional,HPI-COVID-19,,Host-pathogen Interactions During SARS-CoV-2 Infection,Host-pathogen Interactions During Paediatric and Adult SARS-CoV-2 Infection (COVID-19),Recruiting,NA,N/A,450,Anticipated,Hospices Civils de Lyon,,6,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-12T09:13:56Z,2020-05-12T09:13:56Z,5887764,NCT04376476,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-19,NA,NA,2020-05-01,2020-05-01,2020-05-06,Actual,NA,NA,NA,NA,NA,NA,2020-05-01,2020-05-06,Actual,"April 16, 2020",Actual,2020-04-16,May 2020,2020-05-31,"March 30, 2021",Anticipated,2021-03-30,"March 30, 2021",Anticipated,2021-03-30,NA,Interventional,NA,,Convalescent Plasma Collection and Treatment in Pediatrics and Adults,Convalescent Plasma Collection From Individuals That Recovered From COVID19 and Treatment of Critically Ill Individuals With Donor Convalescent Plasma,Recruiting,NA,Phase 3,240,Anticipated,West Virginia University,,3,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-12T09:14:40Z,2020-05-12T09:14:40Z,5887803,NCT04376034,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-05-03,NA,NA,2020-05-03,2020-05-03,2020-05-05,Actual,NA,NA,NA,NA,NA,NA,2020-05-03,2020-05-05,Actual,"April 27, 2020",Actual,2020-04-27,May 2020,2020-05-31,"October 31, 2020",Anticipated,2020-10-31,"June 30, 2020",Anticipated,2020-06-30,NA,Observational,NA,,Monocytes and NK Cells Activity in Covid-19 Patients,Study of Immune-mediated Mechanisms in Patients Tested Positive for SARS-CoV-2: Phenotypic and Functional Analysis of Monocytes and NK Cells in the Blood of Subjects Affected by Covid 19,Recruiting,NA,NA,150,Anticipated,UniversitÃ  degli Studi dell'Insubria,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Venous blood sample (15 mL in EDTA solution test tube).
    ",NA,NA,NA,Undecided,NA,2020-05-12T09:15:24Z,2020-05-12T09:15:24Z,5887912,NCT04375176,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-05-13,NA,NA,2020-05-13,2020-05-13,2020-05-14,Actual,NA,NA,NA,NA,NA,NA,2020-05-13,2020-05-14,Actual,"May 13, 2020",Actual,2020-05-13,May 2020,2020-05-31,"July 10, 2020",Anticipated,2020-07-10,"June 12, 2020",Anticipated,2020-06-12,NA,Observational,NPC-19,,Negative-PCR for Covid- 19 Pneumonia (NPC-19),Negative-PCR for Coronavirus Associated Pneumonia,Recruiting,NA,NA,260,Anticipated,Catholic University of the Sacred Heart,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      plasma samples
    ",NA,NA,NA,NA,NA,2020-05-18T06:30:46Z,2020-05-18T06:30:46Z,5907066,NCT04387799,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-30,NA,NA,2020-05-06,2020-04-30,2020-05-05,Actual,NA,NA,NA,NA,NA,NA,2020-05-06,2020-05-08,Actual,"April 30, 2020",Actual,2020-04-30,May 2020,2020-05-31,"January 30, 2022",Anticipated,2022-01-30,"August 27, 2020",Anticipated,2020-08-27,NA,Interventional,HEROs,,Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus?,"Protecting Frontline Health Care Workers From COVID-19 With Hydroxychloroquine Pre-exposure Prophylaxis: A Randomized, Placebo-controlled Multi-Site Trial in Toronto, Canada",Enrolling by invitation,NA,Phase 3,988,Anticipated,"University Health Network, Toronto",,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,Yes,"At the time of completion of the analysis of primary and secondary outcomes, the HEROS Steering Committee will review all applications for use of participant level data and make recommendations.",2020-05-12T09:15:33Z,2020-05-12T09:15:33Z,5887935,NCT04374942,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-28,NA,NA,2020-04-30,2020-04-30,2020-05-05,Actual,NA,NA,NA,NA,NA,NA,2020-04-30,2020-05-05,Actual,"April 5, 2020",Actual,2020-04-05,April 2020,2020-04-30,June 2020,Anticipated,2020-06-30,June 2020,Anticipated,2020-06-30,NA,Observational,NA,,Quantification of Radiological Pulmonary Involvement in Acute Respiratory Failure,Automated Quantification of Radiological Pulmonary Involvement in Acute Respiratory Failure,Recruiting,NA,NA,100,Anticipated,"University Hospital, Strasbourg, France",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-12T09:15:40Z,2020-05-12T09:15:40Z,5887956,NCT04374734,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-05-02,NA,NA,2020-05-04,2020-05-02,2020-05-05,Actual,NA,NA,NA,NA,NA,NA,2020-05-04,2020-05-06,Actual,"April 1, 2020",Actual,2020-04-01,May 2020,2020-05-31,"May 1, 2020",Actual,2020-05-01,"April 25, 2020",Actual,2020-04-25,NA,Observational,NA,,Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19,Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19,Completed,NA,NA,230,Actual,Hospital Universitari Vall d'Hebron Research Institute,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,We have planned to write a paper,2020-05-12T09:15:43Z,2020-05-12T09:15:43Z,5887981,NCT04374617,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-05-02,NA,NA,2020-05-02,2020-05-02,2020-05-05,Actual,NA,NA,NA,NA,NA,NA,2020-05-02,2020-05-05,Actual,"April 29, 2020",Actual,2020-04-29,May 2020,2020-05-31,"August 29, 2021",Anticipated,2021-08-29,"May 5, 2021",Anticipated,2021-05-05,NA,Interventional,REP-COVID,,Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial,Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial,Recruiting,NA,Phase 2,116,Anticipated,Fundacion Clinic per a la Recerca BiomÃ©dica,,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-12T09:15:46Z,2020-05-12T09:15:46Z,5888001,NCT04374539,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-30,NA,NA,2020-04-30,2020-04-30,2020-05-04,Actual,NA,NA,NA,NA,NA,NA,2020-04-30,2020-05-04,Actual,"April 8, 2020",Actual,2020-04-08,April 2020,2020-04-30,"April 30, 2022",Anticipated,2022-04-30,"April 30, 2022",Anticipated,2022-04-30,NA,Observational,NA,,"Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19","Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19",Recruiting,NA,NA,1000,Anticipated,Stanford University,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Blood sample optional nasopharyngeal swab optional cheek swab with saliva collection
    ",NA,NA,NA,No,NA,2020-05-12T09:16:39Z,2020-05-12T09:16:39Z,5888158,NCT04373148,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-27,NA,NA,2020-05-01,2020-04-29,2020-05-04,Actual,NA,NA,NA,NA,NA,NA,2020-05-01,2020-05-05,Actual,"February 1, 2020",Actual,2020-02-01,May 2020,2020-05-31,"June 30, 2020",Anticipated,2020-06-30,"May 30, 2020",Anticipated,2020-05-30,NA,Interventional,(COVID-19),,Unplanned Shifting to Online Distance Learning: Nursing Students' Perception and Achievement,Unplanned Shifting the Traditional Classroom-Based to Online Distance Learning as a Result of (COVID-19) Social Distancing Measures: Nursing Students' Perception and Achievement,Enrolling by invitation,NA,N/A,180,Anticipated,Kasr El Aini Hospital,,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-12T09:16:56Z,2020-05-12T09:16:56Z,5888198,NCT04372693,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-29,NA,NA,2020-04-30,2020-04-30,2020-05-04,Actual,NA,NA,NA,NA,NA,NA,2020-04-30,2020-05-04,Actual,"April 16, 2020",Actual,2020-04-16,April 2020,2020-04-30,August 2020,Anticipated,2020-08-31,August 2020,Anticipated,2020-08-31,NA,Observational,NA,,Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 Patients,Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 Patients,Recruiting,NA,NA,30,Anticipated,Semmelweis University,,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-12T09:17:02Z,2020-05-12T09:17:02Z,5888210,NCT04372576,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-24,NA,NA,2020-04-29,2020-04-29,2020-05-01,Actual,NA,NA,NA,NA,NA,NA,2020-04-29,2020-05-01,Actual,"April 27, 2020",Actual,2020-04-27,April 2020,2020-04-30,"June 30, 2022",Anticipated,2022-06-30,"June 1, 2021",Anticipated,2021-06-01,NA,Observational,NA,,"Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children","Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children",Recruiting,NA,NA,400,Anticipated,St. Jude Children's Research Hospital,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-12T09:17:50Z,2020-05-12T09:17:50Z,5888339,NCT04371315,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-27,NA,NA,2020-04-30,2020-04-27,2020-04-30,Actual,NA,NA,NA,NA,NA,NA,2020-04-30,2020-05-01,Actual,"April 22, 2020",Actual,2020-04-22,April 2020,2020-04-30,"October 22, 2020",Anticipated,2020-10-22,"October 22, 2020",Anticipated,2020-10-22,NA,Interventional,PredictCovidT,,Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients,Blood Innate Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients,Recruiting,NA,N/A,115,Anticipated,Centre Hospitalier Universitaire de Nice,,1,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-12T09:18:43Z,2020-05-12T09:18:43Z,5888498,NCT04369456,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-22,NA,NA,2020-05-05,2020-04-27,2020-04-29,Actual,NA,NA,NA,NA,NA,NA,2020-05-05,2020-05-07,Actual,"May 4, 2020",Actual,2020-05-04,May 2020,2020-05-31,"September 15, 2022",Anticipated,2022-09-15,"September 15, 2022",Anticipated,2022-09-15,NA,Observational,COVIDSMELL,,Study of the Pathogenesis of Olfactory Disorders in COVID-19,Study of the Pathogenesis of Olfactory Disorders in COVID-19,Recruiting,NA,NA,24,Anticipated,Institut Pasteur,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      Nasal swabs
    ",NA,NA,NA,No,NA,2020-05-12T09:18:56Z,2020-05-12T09:18:56Z,5888549,NCT04366934,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-21,NA,NA,2020-04-29,2020-04-23,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-29,2020-05-04,Actual,"April 24, 2020",Actual,2020-04-24,April 2020,2020-04-30,April 2021,Anticipated,2021-04-30,April 2021,Anticipated,2021-04-30,NA,Interventional,PassItOnII,,Passive Immunity Trial of Nashville II for COVID-19,"A Randomized, Controlled Clinical Trial to Test the Safety and Efficacy of Convalescent Donor Plasma to Treat COVID-19 in Hospitalized Adults",Recruiting,NA,Phase 3,500,Anticipated,Vanderbilt University Medical Center,,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-12T09:19:41Z,2020-05-12T09:19:41Z,5888642,NCT04362176,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-15,NA,NA,2020-05-05,2020-04-17,2020-04-21,Actual,NA,NA,NA,NA,NA,NA,2020-05-05,2020-05-06,Actual,"April 21, 2020",Actual,2020-04-21,April 2020,2020-04-30,"October 18, 2020",Anticipated,2020-10-18,"August 31, 2020",Anticipated,2020-08-31,NA,Interventional,NA,,Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia,Treatment With Inhaled Corticosteroids in Patients Hospitalized Because of COVID19 Pneumonia,Recruiting,NA,Phase 4,300,Anticipated,Fundacion Clinic per a la Recerca BiomÃ©dica,,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-12T09:20:01Z,2020-05-12T09:20:01Z,5888702,NCT04355637,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-13,NA,NA,2020-04-30,2020-04-14,2020-04-15,Actual,NA,NA,NA,NA,NA,NA,2020-04-30,2020-05-01,Actual,"April 14, 2020",Actual,2020-04-14,April 2020,2020-04-30,"June 30, 2021",Anticipated,2021-06-30,"May 30, 2020",Anticipated,2020-05-30,NA,Interventional,PEACE,,Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds,Use and Dosage of Hydroxychloroquine and Chloroquine to Convert Real Time Polymerase Chain Reaction (RT-PCR) Positive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Coronavirus Infectious Disease 2019 (COVID-19) Patients to RT- PCR-Negative as a Means to Reduce Hospitalization Rate,Recruiting,NA,Phase 4,400,Anticipated,"Government of Punjab, Specialized Healthcare and Medical Education Department",,4,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,No,NA,2020-05-12T09:20:37Z,2020-05-12T09:20:37Z,5888791,NCT04346667,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-09,NA,NA,2020-05-07,2020-04-14,2020-04-15,Actual,NA,NA,NA,NA,NA,NA,2020-05-07,2020-05-08,Actual,"April 15, 2020",Actual,2020-04-15,May 2020,2020-05-31,July 2020,Anticipated,2020-07-31,July 2020,Anticipated,2020-07-31,NA,Interventional,NA,,Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients,A Pilot Study to Explore the Efficacy and Safety of Rescue Theraphy With Antibodies From Convalescent Patients Obtained With Double -Filtration Plasmapheresis (DFPP) and Infused in Critically Ill Ventilated Patients With Coronavirus Disease 2019 (COVID-19),Recruiting,NA,N/A,10,Anticipated,A.O. Ospedale Papa Giovanni XXIII,,1,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-12T09:20:38Z,2020-05-12T09:20:38Z,5888797,NCT04346589,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-13,NA,NA,2020-05-06,2020-04-13,2020-04-14,Actual,NA,NA,NA,NA,NA,NA,2020-05-06,2020-05-08,Actual,"May 15, 2020",Anticipated,2020-05-15,April 2020,2020-04-30,"April 1, 2025",Anticipated,2025-04-01,"July 1, 2024",Anticipated,2024-07-01,NA,Observational,NIAID,,Collection of Anti-SARS-CoV-2 Immune Plasma,A Pilot Study for Collection of Anti-SARS-CoV-2 Immune Plasma,Recruiting,NA,NA,1500,Anticipated,National Institutes of Health Clinical Center (CC),,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      Serum, plasma
    ",NA,NA,NA,NA,NA,2020-05-12T09:20:42Z,2020-05-12T09:20:42Z,5888802,NCT04344977,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-09,NA,NA,2020-05-04,2020-04-09,2020-04-14,Actual,NA,NA,NA,NA,NA,NA,2020-05-04,2020-05-06,Actual,"April 15, 2020",Actual,2020-04-15,April 2020,2020-04-30,July 2020,Anticipated,2020-07-31,July 2020,Anticipated,2020-07-31,NA,Interventional,NA,,COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial),COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial),Recruiting,NA,Phase 3,260,Anticipated,"University Hospital, Angers",,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-12T09:20:45Z,2020-05-12T09:20:45Z,5888808,NCT04344041,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-09,NA,NA,2020-05-05,2020-04-10,2020-04-13,Actual,NA,NA,NA,NA,NA,NA,2020-05-05,2020-05-07,Actual,"April 1, 2020",Actual,2020-04-01,May 2020,2020-05-31,"June 1, 2022",Anticipated,2022-06-01,"June 15, 2020",Anticipated,2020-06-15,NA,Observational,STOP-COVID,,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19,Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19,Recruiting,NA,NA,4000,Anticipated,Brigham and Women's Hospital,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-12T09:20:48Z,2020-05-12T09:20:48Z,5888810,NCT04343898,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-09,NA,NA,2020-04-29,2020-04-09,2020-04-13,Actual,NA,NA,NA,NA,NA,NA,2020-04-29,2020-05-01,Actual,"April 18, 2020",Actual,2020-04-18,April 2020,2020-04-30,September 2020,Anticipated,2020-09-30,September 2020,Anticipated,2020-09-30,NA,Interventional,MetCOVID,,Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19,"Efficacy and Safety of Injectable Methylprednisolone Sodium Succinate in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome Under the New Coronavirus (SARS-CoV2): a Phase IIb, Randomized, Double-blind, Placebo-controlled, Clinical Trial.",Recruiting,NA,Phase 2,420,Anticipated,FundaÃ§Ã£o de Medicina Tropical Dr. Heitor Vieira Dourado,,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,after study publication.,upon formal request.,NA,Yes,all patient data will be shared after study publication,2020-05-12T09:20:50Z,2020-05-12T09:20:50Z,5888814,NCT04343729,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-07,NA,NA,2020-05-05,2020-04-07,2020-04-10,Actual,NA,NA,NA,NA,NA,NA,2020-05-05,2020-05-07,Actual,"April 7, 2020",Actual,2020-04-07,May 2020,2020-05-31,"April 30, 2021",Anticipated,2021-04-30,"June 30, 2020",Anticipated,2020-06-30,NA,Interventional,WHIP COVID-19,,Will Hydroxychloroquine Impede or Prevent COVID-19,Will Hydroxychloroquine Impede or Prevent COVID-19: WHIP COVID-19 Study,Recruiting,NA,Phase 3,3000,Anticipated,Henry Ford Health System,,4,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,No,NA,2020-05-12T09:20:59Z,2020-05-12T09:20:59Z,5888847,NCT04341441,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-04,NA,NA,2020-05-07,2020-04-09,2020-04-10,Actual,NA,NA,NA,NA,NA,NA,2020-05-07,2020-05-08,Actual,"April 11, 2020",Actual,2020-04-11,May 2020,2020-05-31,September 2020,Anticipated,2020-09-30,September 2020,Anticipated,2020-09-30,NA,Interventional,NA,,Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19),"A Phase 1b/2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of TJ003234 in Subjects With Severe Coronavirus Disease 2019 (COVID-19)",Recruiting,NA,Phase 1/Phase 2,144,Anticipated,I-Mab Biopharma Co. Ltd.,,3,NA,NA,NA,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-12T09:21:00Z,2020-05-12T09:21:00Z,5888852,NCT04341116,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-03-11,NA,NA,2020-04-28,2020-03-11,2020-03-16,Actual,NA,NA,NA,NA,NA,NA,2020-04-28,2020-05-01,Actual,"March 17, 2020",Actual,2020-03-17,April 2020,2020-04-30,"May 14, 2020",Anticipated,2020-05-14,"May 1, 2020",Anticipated,2020-05-01,NA,Interventional,COVID-19 PEP,,Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2,Post-exposure Prophylaxis or Preemptive Therapy for SARS-Coronavirus-2: A Pragmatic Randomized Clinical Trial,Recruiting,NA,Phase 3,3000,Anticipated,University of Minnesota,,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,NA,NA,,At time of publication,To be publicly provided,http://covidpep.umn.edu,Yes,De-identified dataset will be included with publication.,2020-05-12T09:22:02Z,2020-05-12T09:22:02Z,5889085,NCT04308668,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-02-06,NA,NA,2020-05-05,2020-02-07,2020-02-10,Actual,NA,NA,NA,NA,NA,NA,2020-05-05,2020-05-07,Actual,"February 8, 2020",Actual,2020-02-08,February 2020,2020-02-29,"August 7, 2023",Anticipated,2023-08-07,"August 7, 2020",Anticipated,2020-08-07,NA,Observational,FrenchCOVID,,French COVID Cohort,Clinical Characterisation Protocol for Severe Emerging Infections,Recruiting,NA,NA,5000,Anticipated,"Institut National de la SantÃ© Et de la Recherche MÃ©dicale, France",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Blood, urine, stool /rectal swab, respiratory samples (nose and throat swab, endotracheal
      aspirate, nasopharyngeal aspirate), samples from infected sites/sores, CSF
    ",NA,NA,NA,Undecided,NA,2020-05-12T09:23:14Z,2020-05-12T09:23:14Z,5889400,NCT04262921,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-04-02,NA,NA,2020-04-14,2020-04-03,2020-04-07,Actual,NA,NA,NA,NA,NA,NA,2020-04-14,2020-04-15,Actual,"April 7, 2020",Actual,2020-04-07,April 2020,2020-04-30,"October 21, 2021",Anticipated,2021-10-21,"September 1, 2020",Anticipated,2020-09-01,NA,Observational,NA,,Rutgers COVID-19 Cohort Study,"Cohort Study of SARS-CoV-2 Incidence, Transmission, and Disease Severity in Healthcare Workers",Recruiting,NA,NA,750,Anticipated,"Rutgers, The State University of New Jersey",,NA,3,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      nasopharyngeal or throat swabs, saliva, and blood (for detecting SARS-CoV-2 positivity and
      immunity)
    ",NA,NA,NA,No,NA,2020-05-01T09:25:30Z,2020-05-01T09:25:30Z,5181912,NCT04336215,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-19,NA,NA,2020-03-25,2020-03-24,2020-03-26,Actual,NA,NA,NA,NA,NA,NA,2020-03-25,2020-03-27,Actual,"March 23, 2020",Anticipated,2020-03-23,March 2020,2020-03-31,"May 30, 2020",Anticipated,2020-05-30,"May 20, 2020",Anticipated,2020-05-20,NA,Interventional,MP-C19,,Efficacy of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome,Prolonged Low Doses of Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome,Recruiting,NA,Phase 2/Phase 3,104,Anticipated,University of Trieste,,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,Anonymised data will be available only to data manager who can visualise clinical chart anytime when is needed,2020-05-01T09:27:13Z,2020-05-01T09:27:13Z,5183500,NCT04323592,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-04-15,NA,NA,2020-05-12,2020-05-12,2020-05-13,Actual,NA,NA,NA,NA,NA,NA,2020-05-12,2020-05-13,Actual,"April 1, 2020",Actual,2020-04-01,April 2020,2020-04-30,"September 30, 2021",Anticipated,2021-09-30,"March 31, 2021",Anticipated,2021-03-31,NA,Observational,NA,,Neonatal Complications of Coronavirus Disease (COVID-19),Neonatal Complications of Coronavirus Disease (COVID-19),Recruiting,NA,NA,500,Anticipated,University of Oxford,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,Within 6 months of the study start,Funded registry with appropriate approvals to receive data,NA,Yes,Share relevant data to international registries of neonatal COVID-19 which are being developed.,2020-05-18T06:31:39Z,2020-05-18T06:31:39Z,5907281,NCT04386109,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-05-10,NA,NA,2020-05-12,2020-05-12,2020-05-13,Actual,NA,NA,NA,NA,NA,NA,2020-05-12,2020-05-13,Actual,"June 1, 2020",Anticipated,2020-06-01,May 2020,2020-05-31,"September 1, 2020",Anticipated,2020-09-01,"September 1, 2020",Anticipated,2020-09-01,NA,Interventional,NA,,Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2),Recruiting,NA,Early Phase 1,150,Anticipated,"Ministry of Health, Saudi Arabia",,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,TRUE,NA,,NA,NA,NA,Yes,NA,2020-05-18T06:31:48Z,2020-05-18T06:31:48Z,5907313,NCT04385836,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-05-11,NA,NA,2020-05-12,2020-05-12,2020-05-13,Actual,NA,NA,NA,NA,NA,NA,2020-05-12,2020-05-13,Actual,"March 1, 2020",Actual,2020-03-01,May 2020,2020-05-31,"May 4, 2020",Actual,2020-05-04,"May 4, 2020",Actual,2020-05-04,NA,Observational,NA,,Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure,Use of High Flow Nasal Cannula Oxygen During Acute Hypoxemic Respiratory Failure Related to Covid-19 and Interest of the Respiratory-oxygenation Index (ROX Index): an Observational Study,Completed,NA,NA,62,Actual,HÃ´pital Louis Mourier,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-18T06:31:48Z,2020-05-18T06:31:48Z,5907317,NCT04385823,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-04-29,NA,NA,2020-05-08,2020-05-08,2020-05-12,Actual,NA,NA,NA,NA,NA,NA,2020-05-08,2020-05-12,Actual,"March 13, 2020",Actual,2020-03-13,May 2020,2020-05-31,"April 14, 2020",Actual,2020-04-14,"April 14, 2020",Actual,2020-04-14,NA,Observational,NA,,Outcomes in Hospitalized Older Patients With COVID-19,COVIDAge Study- Hospital Des Trois-ChÃªne,Completed,NA,NA,230,Actual,"University Hospital, Geneva",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-18T06:32:08Z,2020-05-18T06:32:08Z,5907389,NCT04385212,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-05-09,NA,NA,2020-05-11,2020-05-11,2020-05-12,Actual,NA,NA,NA,NA,NA,NA,2020-05-11,2020-05-12,Actual,"May 4, 2020",Actual,2020-05-04,May 2020,2020-05-31,"August 1, 2020",Anticipated,2020-08-01,"August 1, 2020",Anticipated,2020-08-01,NA,Interventional,NA,,Convalescent Plasma for Patients With COVID-19,The Use of Convalescent Plasma for Patients Hospitalized With COVID-19 Disease,Recruiting,NA,Phase 2,30,Anticipated,Henry Ford Health System,,2,NA,NA,NA,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-18T06:32:09Z,2020-05-18T06:32:09Z,5907391,NCT04385199,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-05-11,NA,NA,2020-05-11,2020-05-11,2020-05-12,Actual,NA,NA,NA,NA,NA,NA,2020-05-11,2020-05-12,Actual,"March 30, 2020",Actual,2020-03-30,May 2020,2020-05-31,"December 31, 2020",Anticipated,2020-12-31,"December 31, 2020",Anticipated,2020-12-31,NA,Observational,CovidSurg-Can,,Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis,"Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis: an International, Multicentre, Observational Cohort Study (CovidSurg-Cancer)",Recruiting,NA,NA,1000,Anticipated,University of Birmingham,,NA,2,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,No individual participant data will be made available to other researchers,2020-05-18T06:32:18Z,2020-05-18T06:32:18Z,5907425,NCT04384926,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-04-07,NA,NA,2020-05-10,2020-05-10,2020-05-12,Actual,NA,NA,NA,NA,NA,NA,2020-05-10,2020-05-12,Actual,"April 1, 2020",Actual,2020-04-01,March 2020,2020-03-31,"September 30, 2020",Anticipated,2020-09-30,"June 30, 2020",Anticipated,2020-06-30,NA,Interventional,NA,,Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19,"A Multi-center, Randomized, Open-label, Controlled Trial to Evaluate the Efficacy and Tolerability of Hydroxychloroquine (HCQ) in Adult Patients With Mild to Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment",Recruiting,NA,Phase 4,45,Anticipated,Taoyuan General Hospital,,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,The study outcome will be shared with the experts and persons interested in this field.,2020-05-18T06:32:35Z,2020-05-18T06:32:35Z,5907479,NCT04384380,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-05-07,NA,NA,2020-05-08,2020-05-08,2020-05-12,Actual,NA,NA,NA,NA,NA,NA,2020-05-08,2020-05-12,Actual,"May 6, 2020",Actual,2020-05-06,May 2020,2020-05-31,"June 30, 2021",Anticipated,2021-06-30,"June 30, 2021",Anticipated,2021-06-30,NA,Observational,COSiN,,Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales,Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales,Recruiting,NA,NA,200,Anticipated,Kirby Institute,,NA,2,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,Access to samples and data is governed by the Protocol Steering Committee. Requests can be made to the Committee (via the Principal Investigators).,2020-05-18T06:33:01Z,2020-05-18T06:33:01Z,5907559,NCT04383652,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-05-05,NA,NA,2020-05-10,2020-05-06,2020-05-11,Actual,NA,NA,NA,NA,NA,NA,2020-05-10,2020-05-12,Actual,"February 1, 2020",Actual,2020-02-01,May 2020,2020-05-31,"May 1, 2020",Actual,2020-05-01,"April 30, 2020",Actual,2020-04-30,NA,Observational,NA,,Egyptian Initial Experience About 2019 Novel Corona Virus: Study of 48 Patients in Alexandria-Egypt Using Chest CT,Egyptian Initial Experience About 2019 Novel Corona Virus Disease (COVID-19): Single-center Study Analysis of 48 Patients in Alexandria-Egypt Regarding Radiological Patterns and Co-morbid Lung Diseases,Completed,NA,NA,48,Actual,Alexandria University,,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,"The investigators will recommend further large group future researches for some notices in the study, but preferably not be biased",2020-05-18T06:33:21Z,2020-05-18T06:33:21Z,5907620,NCT04382469,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-04-14,NA,NA,2020-05-12,2020-05-08,2020-05-11,Actual,NA,NA,NA,NA,NA,NA,2020-05-12,2020-05-13,Actual,"May 8, 2020",Actual,2020-05-08,May 2020,2020-05-31,"December 30, 2020",Anticipated,2020-12-30,"September 1, 2020",Anticipated,2020-09-01,NA,Interventional,SAVIORII,,Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms,"A Prospective, Randomized, Controlled Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms (SAVIORII)",Recruiting,NA,N/A,20,Anticipated,Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute),,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,TRUE,NA,NA,TRUE,NA,,NA,NA,NA,No,NA,2020-05-18T06:33:22Z,2020-05-18T06:33:22Z,5907622,NCT04382391,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-05-07,NA,NA,2020-05-14,2020-05-07,2020-05-11,Actual,NA,NA,NA,NA,NA,NA,2020-05-14,2020-05-15,Estimate,"May 8, 2020",Actual,2020-05-08,May 2020,2020-05-31,"July 31, 2020",Anticipated,2020-07-31,"July 31, 2020",Anticipated,2020-07-31,NA,Interventional,NA,,"A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19","A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19",Recruiting,NA,Phase 2,50,Anticipated,MGC Pharmaceuticals d.o.o,,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-18T06:33:24Z,2020-05-18T06:33:24Z,5907634,NCT04382040,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-05-07,NA,NA,2020-05-12,2020-05-07,2020-05-08,Actual,NA,NA,NA,NA,NA,NA,2020-05-12,2020-05-13,Actual,"April 24, 2020",Actual,2020-04-24,May 2020,2020-05-31,"September 16, 2020",Anticipated,2020-09-16,"June 25, 2020",Anticipated,2020-06-25,NA,Interventional,NA,,A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19,"Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical COVID-19 Disease",Recruiting,NA,Phase 2,270,Anticipated,"Janssen Pharmaceutica N.V., Belgium",,2,NA,NA,TRUE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,NA,NA,,NA,NA,https://www.janssen.com/clinical-trials/transparency,Yes,"The data sharing policy of the Janssen Pharmaceutical Companies of Johnson & Johnson is available at www.janssen.com/clinical-trials/transparency.
As noted on this site, requests for access to the study data can be submitted through Yale Open Data Access (YODA) Project site at yoda.yale.edu",2020-05-18T06:33:33Z,2020-05-18T06:33:33Z,5907669,NCT04380961,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-05-01,NA,NA,2020-05-13,2020-05-06,2020-05-07,Actual,NA,NA,NA,NA,NA,NA,2020-05-13,2020-05-14,Actual,"May 1, 2020",Actual,2020-05-01,May 2020,2020-05-31,December 2021,Anticipated,2021-12-31,December 2020,Anticipated,2020-12-31,NA,Observational,IMPACC,,Immunophenotyping Assessment in a COVID-19 Cohort,A Prospective Cohort Study to Assess Longitudinal Immune Responses in Hospitalized Patients With COVID-19 (DAIT-COVID-19-002),Enrolling by invitation,NA,NA,2000,Anticipated,National Institute of Allergy and Infectious Diseases (NIAID),,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      -  nasal secretion samples

        -  whole blood

        -  sputum secretions by endotracheal aspiration (for intubated patients)
    ",NA,NA,NA,NA,NA,2020-05-18T06:33:42Z,2020-05-18T06:33:42Z,5907701,NCT04378777,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 06, 2020",2020-03-20,NA,NA,2020-04-23,2020-03-20,2020-03-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-23,2020-04-27,Actual,"March 29, 2020",Actual,2020-03-29,April 2020,2020-04-30,March 2022,Anticipated,2022-03-31,March 2021,Anticipated,2021-03-31,NA,Interventional,NA,,Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19),Hydroxychloroquine Post Exposure Prophylaxis (PEP) for Household Contacts of COVID-19 Patients: A NYC Community-Based Randomized Clinical Trial,Recruiting,NA,Phase 2/Phase 3,1600,Anticipated,Columbia University,,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,TRUE,NA,,NA,NA,NA,No,NA,2020-05-07T09:16:25Z,2020-05-07T09:16:25Z,5808172,NCT04318444,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-04-30,NA,NA,2020-05-14,2020-05-04,2020-05-05,Actual,NA,NA,NA,NA,NA,NA,2020-05-14,2020-05-15,Estimate,"May 1, 2020",Actual,2020-05-01,May 2020,2020-05-31,December 2020,Anticipated,2020-12-31,December 2020,Anticipated,2020-12-31,NA,Observational,HEROS,,COVID-19: Human Epidemiology and Response to SARS-CoV-2,Human Epidemiology and Response to SARS-CoV-2 (DAIT-COVID-19-001),Enrolling by invitation,NA,NA,8000,Anticipated,National Institute of Allergy and Infectious Diseases (NIAID),,NA,1,NA,FALSE,NA,NA,NA,FALSE,NA,NA,NA,NA,NA,Samples With DNA,"
      Nasal, peripheral blood and stool samples
    ",NA,NA,NA,NA,NA,2020-05-18T06:33:51Z,2020-05-18T06:33:51Z,5907727,NCT04375761,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-05-04,NA,NA,2020-05-08,2020-05-04,2020-05-05,Actual,NA,NA,NA,NA,NA,NA,2020-05-08,2020-05-12,Actual,"March 15, 2020",Actual,2020-03-15,April 2020,2020-04-30,"August 31, 2021",Anticipated,2021-08-31,"June 30, 2021",Anticipated,2021-06-30,NA,Observational,NA,,Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19);,Health-related Quality of Life (HRQOL) and Physical Performance in Individuals After COVID-19 Induced Hospitalisation and the Impact of a Standard Care Follow-up Program: a Longitudinal Observational Cohort Study,Recruiting,NA,NA,60,Anticipated,Kantonsspital Winterthur KSW,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-18T06:33:51Z,2020-05-18T06:33:51Z,5907729,NCT04375709,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-04-29,NA,NA,2020-05-14,2020-04-30,2020-05-01,Actual,NA,NA,NA,NA,NA,NA,2020-05-14,2020-05-15,Estimate,"May 20, 2020",Anticipated,2020-05-20,"May 7, 2020",2020-05-07,"June 1, 2025",Anticipated,2025-06-01,"June 1, 2025",Anticipated,2025-06-01,NA,Observational,NA,,Genetics of COVID-19 Susceptibility and Manifestations,Genetics of COVID-19 Susceptibility and Manifestations,Recruiting,NA,NA,2500,Anticipated,National Institutes of Health Clinical Center (CC),,NA,2,NA,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-18T06:34:00Z,2020-05-18T06:34:00Z,5907756,NCT04371432,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-04-28,NA,NA,2020-05-10,2020-04-28,2020-04-30,Actual,NA,NA,NA,NA,NA,NA,2020-05-10,2020-05-12,Actual,"May 1, 2020",Anticipated,2020-05-01,May 2020,2020-05-31,"August 1, 2021",Anticipated,2021-08-01,"May 1, 2021",Anticipated,2021-05-01,12 Months,Observational [Patient Registry],NA,,Hungarian COVID-19 Epidemiological Research,Hungarian CoronaVirus Disease-19 Epidemiological Research,Recruiting,NA,NA,11200,Anticipated,Semmelweis University Heart and Vascular Center,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-18T06:34:04Z,2020-05-18T06:34:04Z,5907762,NCT04370067,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-04-20,NA,NA,2020-04-21,2020-04-21,2020-04-22,Actual,NA,NA,NA,NA,NA,NA,2020-04-21,2020-04-22,Actual,"April 15, 2020",Actual,2020-04-15,April 2020,2020-04-30,"April 30, 2020",Anticipated,2020-04-30,"April 20, 2020",Anticipated,2020-04-20,NA,Observational,SCout,,Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections,Risk Stratification With Chest Computed Tomography to Rule-out Suspected SARS-CoV-2 Infections of Unspecific Symptomatic Patients Before Hospital Admission,"Active, not recruiting",NA,NA,145,Anticipated,Jena University Hospital,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,There is not a plan to make IPD available.,2020-05-02T09:11:42Z,2020-05-02T09:11:42Z,5753788,NCT04357938,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-04-17,NA,NA,2020-05-11,2020-04-17,2020-04-21,Actual,NA,NA,NA,NA,NA,NA,2020-05-11,2020-05-12,Actual,"May 11, 2020",Actual,2020-05-11,May 2020,2020-05-31,November 2020,Anticipated,2020-11-30,August 2020,Anticipated,2020-08-31,NA,Observational,NA,,Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel.,AntikÃ¶rperseroprÃ¤valenz Und Hintergrundinfektionsrate Von SARS-CoV-2 in Einem Ã¶sterreichischen SchlÃ¼sselkollektiv an Arbeitnehmer*Innen,Recruiting,NA,NA,4000,Anticipated,AUVA,,NA,1,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,IPD will be encrypted and anonymised.,2020-05-18T06:34:35Z,2020-05-18T06:34:35Z,5907852,NCT04354779,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-04-15,NA,NA,2020-05-08,2020-04-15,2020-04-17,Actual,NA,NA,NA,NA,NA,NA,2020-05-08,2020-05-12,Actual,"April 30, 2020",Actual,2020-04-30,May 2020,2020-05-31,September 2020,Anticipated,2020-09-30,September 2020,Anticipated,2020-09-30,NA,Interventional,NA,,Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Hospitalized Patients With COVID-19 Pneumonia,"A Phase 3 Randomized, Placebo-Controlled Study of Lenzilumab in Hospitalized Patients With COVID-19 Pneumonia",Recruiting,NA,Phase 3,238,Anticipated,"Humanigen, Inc.",,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Yes,NA,2020-05-18T06:34:41Z,2020-05-18T06:34:41Z,5907863,NCT04351152,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-04-11,NA,NA,2020-05-13,2020-04-11,2020-04-15,Actual,NA,NA,NA,NA,NA,NA,2020-05-13,2020-05-15,Estimate,"May 20, 2020",Anticipated,2020-05-20,May 2020,2020-05-31,"July 30, 2020",Anticipated,2020-07-30,"July 25, 2020",Anticipated,2020-07-25,NA,Interventional,HNS-COVID-PK,,Honey & Nigella Sativa-COVID-Pakistan Trial Against COVID-19,"The Role of Honey and Nigella Sativa in the Management of COVID-19; A Randomized Controlled, Open-label, Add-on Trial in Lahore, Pakistan",Recruiting,NA,Phase 3,30,Anticipated,Sheikh Zayed Federal Postgraduate Medical Institute,,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-18T06:34:51Z,2020-05-18T06:34:51Z,5907892,NCT04347382,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-04-13,NA,NA,2020-05-08,2020-04-14,2020-04-15,Actual,NA,NA,NA,NA,NA,NA,2020-05-08,2020-05-12,Actual,"April 15, 2020",Actual,2020-04-15,May 2020,2020-05-31,"April 1, 2021",Anticipated,2021-04-01,"December 31, 2020",Anticipated,2020-12-31,NA,Interventional,NA,,Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19),"A Phase 2b/3, Randomized, Double Blind, Placebo Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19)",Recruiting,NA,Phase 2,390,Anticipated,"CytoDyn, Inc.",,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-18T06:34:52Z,2020-05-18T06:34:52Z,5907894,NCT04347239,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-03-31,NA,NA,2020-05-08,2020-04-09,2020-04-13,Actual,NA,NA,NA,NA,NA,NA,2020-05-08,2020-05-12,Actual,"April 1, 2020",Actual,2020-04-01,May 2020,2020-05-31,"April 4, 2021",Anticipated,2021-04-04,"December 4, 2020",Anticipated,2020-12-04,NA,Interventional,NA,,Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19,"A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate Coronavirus Disease 2019 (COVID-19)",Recruiting,NA,Phase 2,75,Anticipated,"CytoDyn, Inc.",,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-18T06:34:58Z,2020-05-18T06:34:58Z,5907914,NCT04343651,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-04-08,NA,NA,2020-05-12,2020-04-08,2020-04-13,Actual,NA,NA,NA,NA,NA,NA,2020-05-12,2020-05-13,Actual,"April 10, 2020",Actual,2020-04-10,May 2020,2020-05-31,"April 1, 2021",Anticipated,2021-04-01,"December 1, 2020",Anticipated,2020-12-01,NA,Interventional,NA,,Convalescent Plasma in the Treatment of COVID 19,Convalescent Plasma in the Treatment of COVID 19,Enrolling by invitation,NA,Phase 2,45,Anticipated,Saint Francis Care,,1,NA,NA,FALSE,NA,NA,NA,FALSE,TRUE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-18T06:34:59Z,2020-05-18T06:34:59Z,5907917,NCT04343261,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-04-03,NA,NA,2020-05-12,2020-04-08,2020-04-13,Actual,NA,NA,NA,NA,NA,NA,2020-05-12,2020-05-14,Actual,"April 8, 2020",Actual,2020-04-08,May 2020,2020-05-31,"June 30, 2021",Anticipated,2021-06-30,"June 30, 2020",Anticipated,2020-06-30,NA,Interventional,ATTAC-Co,,Pro-thrombotic Status in Patients With SARS-Cov-2 Infection,"Patterns and Changes in Platelet Reactivity, Thrombotic Status and Endothelial Function in Hospitalized Patients With SARS-Cov-2 Infection",Recruiting,NA,N/A,60,Anticipated,University Hospital of Ferrara,,1,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Yes,After specific request to study PIs,2020-05-18T06:34:59Z,2020-05-18T06:34:59Z,5907918,NCT04343053,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-04-08,NA,NA,2020-05-12,2020-04-08,2020-04-13,Actual,NA,NA,NA,NA,NA,NA,2020-05-12,2020-05-14,Actual,"April 8, 2020",Actual,2020-04-08,May 2020,2020-05-31,"April 30, 2021",Anticipated,2021-04-30,"December 30, 2020",Anticipated,2020-12-30,NA,Interventional,COVIDAtoZ,,Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation,"Coronavirus Disease 2019- Using Ascorbic Acid and Zinc Supplementation (COVIDAtoZ) Research Study A Randomized, Open Label Single Center Study",Enrolling by invitation,NA,N/A,520,Anticipated,The Cleveland Clinic,,4,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,NA,NA,2020-05-18T06:35:00Z,2020-05-18T06:35:00Z,5907921,NCT04342728,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-28,NA,NA,2020-04-28,2020-04-28,2020-04-29,Actual,NA,NA,NA,NA,NA,NA,2020-04-28,2020-04-30,Actual,"April 18, 2020",Actual,2020-04-18,April 2020,2020-04-30,October 2021,Anticipated,2021-10-31,October 2021,Anticipated,2021-10-31,1 Year,Observational [Patient Registry],NA,,ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers,SARS-CoV-2 Seroprevalence Among Healthcare Workers: ARMOR Study Demonstration Project,Recruiting,NA,NA,1000,Anticipated,Columbia University,,NA,4,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-11T18:32:15Z,2020-05-11T18:32:15Z,5876500,NCT04367857,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-04-07,NA,NA,2020-05-12,2020-04-07,2020-04-10,Actual,NA,NA,NA,NA,NA,NA,2020-05-12,2020-05-13,Actual,"April 9, 2020",Actual,2020-04-09,May 2020,2020-05-31,July 2020,Anticipated,2020-07-31,July 2020,Anticipated,2020-07-31,NA,Interventional,SOS-COVID19,,Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome,Randomized Double Blinded Monocentric Clinical Trial to Assess the Impact of Auricular Vagus Nerve Neuromodulation in COVID-19 Positive Inpatients Outcome.,Recruiting,NA,N/A,60,Anticipated,Fondation Ophtalmologique Adolphe de Rothschild,,2,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-18T06:35:02Z,2020-05-18T06:35:02Z,5907930,NCT04341415,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-04-07,NA,NA,2020-05-13,2020-04-08,2020-04-09,Actual,NA,NA,NA,NA,NA,NA,2020-05-13,2020-05-14,Actual,"April 10, 2020",Actual,2020-04-10,May 2020,2020-05-31,"December 31, 2021",Anticipated,2021-12-31,"December 31, 2020",Anticipated,2020-12-31,NA,Interventional,NA,,COVID-19 Convalescent Plasma,Pilot Study for Use of Convalescent Plasma Collected From Patients Recovered From COVID-19 Disease for Transfusion as an Empiric Treatment During the 2020 Pandemic at the University of Chicago Medical Center,"Active, not recruiting",NA,Early Phase 1,10,Actual,University of Chicago,,1,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,TRUE,NA,,Upon publication of the major manuscript to be generated from this study. Data will be deposited in an appropriate major database,NA,NA,Yes,We will share individual participant data that is de-identified available to all qualified investigators,2020-05-18T06:35:03Z,2020-05-18T06:35:03Z,5907932,NCT04340050,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-04-06,NA,NA,2020-05-11,2020-04-06,2020-04-09,Actual,NA,NA,NA,NA,NA,NA,2020-05-11,2020-05-12,Actual,"April 15, 2020",Actual,2020-04-15,May 2020,2020-05-31,October 2020,Anticipated,2020-10-31,October 2020,Anticipated,2020-10-31,NA,Observational,NA,,Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS),Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS),Recruiting,NA,NA,500,Anticipated,University of Minnesota,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-18T06:35:03Z,2020-05-18T06:35:03Z,5907933,NCT04339998,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-04-13,NA,NA,2020-04-17,2020-04-14,2020-04-15,Actual,NA,NA,NA,NA,NA,NA,2020-04-17,2020-04-20,Actual,"April 14, 2020",Actual,2020-04-14,April 2020,2020-04-30,"December 1, 2020",Anticipated,2020-12-01,"October 1, 2020",Anticipated,2020-10-01,NA,Observational,Explore,,Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19,Retrospective Study From November 2019 -Febrauary 2020 on Severe Respiratory Illness to Access the Presence or Absence of COVID-19 in Patients Samples by Real-time PcR,Recruiting,NA,NA,500,Anticipated,Ain Shams University,,NA,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Oropharyngeal and nasopharyngeal swabs for hospitalized SARI patients who meet the WHO
      standard SARI case definition.
    ",NA,NA,NA,No,NA,2020-05-01T09:24:16Z,2020-05-01T09:24:16Z,5180843,NCT04346056,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-23,NA,NA,2020-04-15,2020-03-27,2020-03-31,Actual,NA,NA,NA,NA,NA,NA,2020-04-15,2020-04-16,Actual,"March 23, 2020",Actual,2020-03-23,April 2020,2020-04-30,"March 23, 2022",Anticipated,2022-03-23,"March 23, 2022",Anticipated,2022-03-23,NA,Interventional,EPI-COVID-19,,Household Transmission Investigation Study for COVID-19 in French Guiana,Household Transmission Investigation Study for Coronavirus Disease 2019 (COVID-19) in French Guiana,Recruiting,NA,N/A,450,Anticipated,Institut Pasteur,,2,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-01T09:26:34Z,2020-05-01T09:26:34Z,5182897,NCT04328129,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-09,NA,NA,2020-04-07,2020-03-11,2020-03-12,Actual,NA,NA,NA,NA,NA,NA,2020-04-07,2020-04-09,Actual,"March 21, 2020",Actual,2020-03-21,April 2020,2020-04-30,"April 1, 2022",Anticipated,2022-04-01,"April 1, 2021",Anticipated,2021-04-01,NA,Interventional,NoCovid,,Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19,Nitric Oxide Gas Inhalation Therapy in Spontaneous Breathing Patients With Mild/Moderate COVID-19: a Randomized Clinical Trial,Recruiting,NA,Phase 2,240,Anticipated,Massachusetts General Hospital,,2,NA,NA,FALSE,NA,NA,NA,NA,TRUE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,NA,NA,2020-05-01T09:29:33Z,2020-05-01T09:29:33Z,5185875,NCT04305457,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-04-06,NA,NA,2020-05-10,2020-04-06,2020-04-08,Actual,NA,NA,NA,NA,NA,NA,2020-05-10,2020-05-12,Actual,"May 8, 2020",Actual,2020-05-08,May 2020,2020-05-31,"September 30, 2020",Anticipated,2020-09-30,"July 31, 2020",Anticipated,2020-07-31,NA,Interventional,NOCOVID,,Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection,"Multi-Center, Randomized, Controlled, Phase II Clinical Efficacy Study Evaluating Nitric Oxide Releasing Solution Treatment for the Prevention and Treatment of COVID-19 in Healthcare Workers and Individuals at Risk of Infection",Recruiting,NA,Phase 2,200,Anticipated,Sanotize Research and Development corp.,,3,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-18T06:35:06Z,2020-05-18T06:35:06Z,5907956,NCT04337918,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-03-31,NA,NA,2020-05-13,2020-04-01,2020-04-02,Actual,NA,NA,NA,NA,NA,NA,2020-05-13,2020-05-14,Actual,"April 13, 2020",Actual,2020-04-13,March 2020,2020-03-31,March 2021,Anticipated,2021-03-31,March 2021,Anticipated,2021-03-31,NA,Observational,COVID-19,,An Observational Study of Patients With Coronavirus Disease 2019,An Observational Study of Patients With Coronavirus Disease 2019,Recruiting,NA,NA,5000,Anticipated,"Target PharmaSolutions, Inc.",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-18T06:35:12Z,2020-05-18T06:35:12Z,5907987,NCT04331886,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-03-23,NA,NA,2020-05-12,2020-03-29,2020-04-01,Actual,NA,NA,NA,NA,NA,NA,2020-05-12,2020-05-14,Actual,"March 31, 2020",Actual,2020-03-31,May 2020,2020-05-31,"October 31, 2020",Anticipated,2020-10-31,"September 30, 2020",Anticipated,2020-09-30,NA,Interventional,NA,,Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP),"Efficacy of Hydroxychloroquine for Post-exposure Prophylaxis (PEP) to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Adults Exposed to Coronavirus Disease (COVID-19): a Blinded, Randomized Study",Recruiting,NA,Phase 2/Phase 3,2000,Anticipated,University of Washington,,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,FALSE,NA,,Within 3 months of publication of primary results.,De-identified data from the study will be made available in accordance with the funder's open access policy.,https://www.gatesfoundation.org/how-we-work/general-information/open-access-policy,Yes,De-identified data from the study will be made available in accordance with the funder's open access policy.,2020-05-18T06:35:14Z,2020-05-18T06:35:14Z,5907999,NCT04328961,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-03-26,NA,NA,2020-05-09,2020-03-26,2020-03-31,Actual,NA,NA,NA,NA,NA,NA,2020-05-09,2020-05-12,Actual,"March 28, 2020",Actual,2020-03-28,May 2020,2020-05-31,August 2020,Anticipated,2020-08-31,July 2020,Anticipated,2020-07-31,NA,Interventional,NA,,Sarilumab COVID-19,"An Adaptive Phase 3, Randomized, Double-blind, Placebo-controlled Study Assessing Efficacy and Safety of Sarilumab for Hospitalized Patients With COVID19",Recruiting,NA,Phase 3,400,Anticipated,Sanofi,,3,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,TRUE,NA,,NA,NA,NA,Yes,"Qualified researchers may request access to patient level data and related study documents including the clinical study report, study protocol with any amendments, blank case report form, statistical analysis plan, and dataset specifications. Patient level data will be anonymized and study documents will be redacted to protect the privacy of trial participants. Further details on Sanofi's data sharing criteria, eligible studies, and process for requesting access can be found at: https://www.clinicalstudydatarequest.com/",2020-05-18T06:35:15Z,2020-05-18T06:35:15Z,5908005,NCT04327388,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 07, 2020",2020-04-07,NA,NA,2020-04-25,2020-04-25,2020-04-28,Actual,NA,NA,NA,NA,NA,NA,2020-04-25,2020-04-28,Actual,"April 6, 2020",Actual,2020-04-06,April 2020,2020-04-30,"December 1, 2020",Anticipated,2020-12-01,"October 1, 2020",Anticipated,2020-10-01,NA,Interventional,BRACE-CORONA,,Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19,Suspension of Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Hospitalized Patients With Coronavirus Infection (COVID-19). A Randomized Trial,Recruiting,NA,N/A,500,Anticipated,D'Or Institute for Research and Education,,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-08T09:14:03Z,2020-05-08T09:14:03Z,5820120,NCT04364893,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-03-25,NA,NA,2020-05-11,2020-03-25,2020-03-26,Actual,NA,NA,NA,NA,NA,NA,2020-05-11,2020-05-12,Actual,"January 1, 2020",Actual,2020-01-01,May 2020,2020-05-31,"September 30, 2020",Anticipated,2020-09-30,"September 30, 2020",Anticipated,2020-09-30,NA,Observational,CovidSurg,,Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg),Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg),Recruiting,NA,NA,1000,Anticipated,University of Birmingham,,NA,1,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,No individual participant data will be available to other researchers,2020-05-18T06:35:19Z,2020-05-18T06:35:19Z,5908023,NCT04323644,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-03-10,NA,NA,2020-05-12,2020-03-10,2020-03-13,Actual,NA,NA,NA,NA,NA,NA,2020-05-12,2020-05-13,Actual,"March 19, 2020",Actual,2020-03-19,May 2020,2020-05-31,"December 31, 2020",Anticipated,2020-12-31,"September 1, 2020",Anticipated,2020-09-01,NA,Observational,NA,,Acute Respiratory Failure and COVID-19 in Real Life,Acute Respiratory Failure and Continuous Positive Airway Pressure Therapy in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: a Real Life Evaluation,Recruiting,NA,NA,50,Anticipated,University of Milan,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-18T06:35:41Z,2020-05-18T06:35:41Z,5908122,NCT04307459,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 15, 2020",2020-02-18,NA,NA,2020-05-13,2020-02-18,2020-02-20,Actual,NA,NA,NA,NA,NA,NA,2020-05-13,2020-05-14,Actual,"March 5, 2020",Actual,2020-03-05,October 2019,2019-10-31,"April 24, 2024",Anticipated,2024-04-24,"April 24, 2024",Anticipated,2024-04-24,NA,Observational,POPS or POP02,,"Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)","Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs",Recruiting,NA,NA,5000,Anticipated,Duke University,,NA,1,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Whole blood, effluent samples, and plasma.
    ",NA,NA,NA,No,NA,2020-05-18T06:36:07Z,2020-05-18T06:36:07Z,5908210,NCT04278404,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 06, 2020",2020-04-22,NA,NA,2020-04-24,2020-04-24,2020-04-27,Actual,NA,NA,NA,NA,NA,NA,2020-04-24,2020-04-27,Actual,"April 23, 2020",Actual,2020-04-23,April 2020,2020-04-30,"March 20, 2025",Anticipated,2025-03-20,"April 20, 2021",Anticipated,2021-04-20,NA,Observational,NA,,St. Jude Tracking of Viral and Host Factors Associated With COVID-19,SJTRC-St. Jude Tracking of Viral and Host Factors Associated With COVID-19: A Prospective Adaptive Cohort Study,Recruiting,NA,NA,1517,Anticipated,St. Jude Children's Research Hospital,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      blood and nasal samples
    ",NA,NA,NA,NA,NA,2020-05-07T09:12:56Z,2020-05-07T09:12:56Z,5807520,NCT04362995,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-04-20,NA,NA,2020-04-20,2020-04-20,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-20,2020-04-24,Actual,May 2020,Anticipated,2020-05-31,April 2020,2020-04-30,September 2022,Anticipated,2022-09-30,May 2022,Anticipated,2022-05-31,NA,Observational,STOP COVID 19,,Sequencing and Tracking of Phylogeny in COVID-19 Study,Sequencing and Tracking of Phylogeny in COVID-19 Study,Recruiting,NA,NA,500,Anticipated,Portsmouth Hospitals NHS Trust,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-04T09:02:33Z,2020-05-04T09:02:33Z,5776392,NCT04359849,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-04-20,NA,NA,2020-04-20,2020-04-20,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-20,2020-04-24,Actual,"April 16, 2020",Actual,2020-04-16,April 2020,2020-04-30,"July 31, 2021",Anticipated,2021-07-31,"April 30, 2021",Anticipated,2021-04-30,NA,Observational,NA,,A Study to Explore the Role of Gut Flora in COVID-19 Infection,A Non-Interventional Pilot Study to Explore the Role of Gut Flora in COVID-19 Infection,Recruiting,NA,NA,250,Anticipated,ProgenaBiome,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Stool samples.
    ",NA,NA,NA,No,NA,2020-05-04T09:02:34Z,2020-05-04T09:02:34Z,5776396,NCT04359836,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-04-21,NA,NA,2020-04-21,2020-04-21,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-21,2020-04-24,Actual,"April 9, 2020",Actual,2020-04-09,April 2020,2020-04-30,"April 22, 2020",Anticipated,2020-04-22,"April 22, 2020",Anticipated,2020-04-22,NA,Observational,PSY_CO_CHU,,Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey,Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey,Recruiting,NA,NA,2000,Anticipated,Centre Hospitalier Universitaire de NÄ«mes,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-04T09:03:27Z,2020-05-04T09:03:27Z,5776522,NCT04358640,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-04-15,NA,NA,2020-04-22,2020-04-18,2020-04-22,Actual,NA,NA,NA,NA,NA,NA,2020-04-22,2020-04-24,Actual,"April 16, 2020",Actual,2020-04-16,April 2020,2020-04-30,"July 31, 2020",Anticipated,2020-07-31,"May 31, 2020",Anticipated,2020-05-31,NA,Interventional,NA,,Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19),Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19): a Diagnostic Accuracy Study,Recruiting,NA,N/A,100,Anticipated,UniversitÃ  degli Studi dell'Insubria,,2,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,"Data will be available at the end of the study, once statistical analyses is conducted",Contact Principal Investigator,NA,Yes,"We could provide anamnestic, clinical and serological data of each participant at the end of the study, or at least at the end of the first phase.",2020-05-04T09:03:57Z,2020-05-04T09:03:57Z,5776611,NCT04357327,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-04-01,NA,NA,2020-04-22,2020-04-02,2020-04-03,Actual,NA,NA,NA,NA,NA,NA,2020-04-22,2020-04-24,Actual,"April 12, 2020",Actual,2020-04-12,April 2020,2020-04-30,May 2020,Anticipated,2020-05-31,May 2020,Anticipated,2020-05-31,NA,Interventional,NA,,Hydroxychloroquine in Outpatient Adults With COVID-19,"A Phase 1b, Randomized, Double-blinded, Placebo-controlled Study of Hydroxychloroquine in Outpatient Adults With COVID-19",Recruiting,NA,Phase 1,210,Anticipated,Sanofi,,2,NA,NA,FALSE,NA,NA,NA,FALSE,TRUE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Yes,"Qualified researchers may request access to patient level data and related study documents including the clinical study report, study protocol with any amendments, blank case report form, statistical analysis plan, and dataset specifications. Patient level data will be anonymized and study documents will be redacted to protect the privacy of trial participants. Further details on Sanofi's data sharing criteria, eligible studies, and process for requesting access can be found at: https://www.clinicalstudydatarequest.com/",2020-05-04T09:05:55Z,2020-05-04T09:05:55Z,5776934,NCT04333654,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-03-31,NA,NA,2020-04-22,2020-03-31,2020-04-03,Actual,NA,NA,NA,NA,NA,NA,2020-04-22,2020-04-24,Actual,"April 2, 2020",Actual,2020-04-02,April 2020,2020-04-30,July 2021,Anticipated,2021-07-31,April 2021,Anticipated,2021-04-30,NA,Interventional,ORCHID,,Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease,Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease,Recruiting,NA,Phase 3,510,Anticipated,Massachusetts General Hospital,,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-04T09:05:57Z,2020-05-04T09:05:57Z,5776947,NCT04332991,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-04-14,NA,NA,2020-04-21,2020-04-21,2020-04-22,Actual,NA,NA,NA,NA,NA,NA,2020-04-21,2020-04-22,Actual,"April 13, 2020",Actual,2020-04-13,April 2020,2020-04-30,August 2020,Anticipated,2020-08-31,July 2020,Anticipated,2020-07-31,NA,Interventional,COPLA,,COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma,COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma,Recruiting,NA,Phase 2,10,Anticipated,Centro de HematologÃ­a y Medicina Interna,,1,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-02T09:12:10Z,2020-05-02T09:12:10Z,5753890,NCT04357106,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-04-16,NA,NA,2020-04-18,2020-04-17,2020-04-20,Actual,NA,NA,NA,NA,NA,NA,2020-04-18,2020-04-21,Actual,"February 19, 2020",Actual,2020-02-19,April 2020,2020-04-30,"April 6, 2020",Actual,2020-04-06,"April 4, 2020",Actual,2020-04-04,NA,Observational,NA,,Echocardiographic Manifestation in Patient With Coronavirus Disease 2019 (COVID-19),Cardiac Structural and Functional Characteristics in Coronavirus Disease 2019 (COVID-19): A Dynamic Echocardiographic Study,Completed,NA,NA,55,Actual,RenJi Hospital,,NA,2,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-01T09:23:23Z,2020-05-01T09:23:23Z,5180130,NCT04352842,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-04-21,NA,NA,2020-04-23,2020-04-23,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-23,2020-04-24,Actual,"April 17, 2020",Actual,2020-04-17,April 2020,2020-04-30,July 2020,Anticipated,2020-07-31,July 2020,Anticipated,2020-07-31,NA,Interventional,CytokCOVID19,,Pilot Study on Cytokine Filtration in COVID-19 ARDS,Pilot Study on Cytokine Filtration in COVID-19 ARDS (CytokCOVID19),Recruiting,NA,N/A,40,Anticipated,Hospital Clinic of Barcelona,,2,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-04T09:01:25Z,2020-05-04T09:01:25Z,5776205,NCT04361526,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-04-16,NA,NA,2020-04-22,2020-04-22,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-22,2020-04-24,Actual,"April 8, 2020",Actual,2020-04-08,April 2020,2020-04-30,"December 30, 2021",Anticipated,2021-12-30,"July 1, 2021",Anticipated,2021-07-01,NA,Observational,COVID19 LTFU,,Long Term Outcomes of Patients With COVID-19,Long Term Outcomes of Patients With COVID-19,Recruiting,NA,NA,500,Anticipated,University of Chicago,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-04T09:02:07Z,2020-05-04T09:02:07Z,5776305,NCT04360538,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-04-06,NA,NA,2020-04-08,2020-04-08,2020-04-09,Actual,NA,NA,NA,NA,NA,NA,2020-04-08,2020-04-09,Actual,"March 27, 2020",Actual,2020-03-27,April 2020,2020-04-30,"December 31, 2020",Anticipated,2020-12-31,"October 6, 2020",Anticipated,2020-10-06,NA,Interventional,NA,,Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection,Randomized Open Label Study of Standard of Care Plus an Angiotensin II Receptor Blocker Compared to Standard of Care Alone to Minimize the Progression to Respiratory Failure in SARS-CoV-2 Infection,Recruiting,NA,Phase 4,200,Anticipated,Sharp HealthCare,,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,No,NA,2020-05-01T09:24:57Z,2020-05-01T09:24:57Z,5181429,NCT04340557,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-04-05,NA,NA,2020-04-09,2020-04-07,2020-04-08,Actual,NA,NA,NA,NA,NA,NA,2020-04-09,2020-04-13,Actual,"April 9, 2020",Actual,2020-04-09,April 2020,2020-04-30,"June 1, 2020",Anticipated,2020-06-01,"June 1, 2020",Anticipated,2020-06-01,NA,Interventional,HOME-CoV,,HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With a SARS-CoV-2 Infection,HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With Confirmed or Probable SARS-CoV-2 Infection. A Before and After Implementation of a Consensus Help-decision Making Rule Study,Recruiting,NA,N/A,4000,Anticipated,"University Hospital, Angers",,2,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-01T09:25:10Z,2020-05-01T09:25:10Z,5181634,NCT04338841,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-04-01,NA,NA,2020-04-16,2020-04-02,2020-04-03,Actual,NA,NA,NA,NA,NA,NA,2020-04-16,2020-04-17,Actual,"April 15, 2020",Actual,2020-04-15,April 2020,2020-04-30,"June 1, 2020",Anticipated,2020-06-01,"June 1, 2020",Anticipated,2020-06-01,NA,Interventional,NA,,Treatment of SARS Caused by COVID-19 With Ruxolitinib,Treatment of Severe Acute Respiratory Syndrome Caused by COVID-19 With Ruxolitinib,Recruiting,NA,Phase 1/Phase 2,20,Anticipated,Grupo Cooperativo de HemopatÃ­as Malignas,,1,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-01T09:25:46Z,2020-05-01T09:25:46Z,5182192,NCT04334044,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-27,NA,NA,2020-03-30,2020-03-30,2020-03-31,Actual,NA,NA,NA,NA,NA,NA,2020-03-30,2020-03-31,Actual,"January 30, 2020",Actual,2020-01-30,March 2020,2020-03-31,"April 15, 2020",Anticipated,2020-04-15,"April 2, 2020",Anticipated,2020-04-02,NA,Observational,NA,,Clinical Characteristics and Prognostic Factors of Patients With COVID-19,Clinical Characteristics and Prognostic Factors of Patients With COVID-19 in Chibi Hospital of Hubei Province,Recruiting,NA,NA,120,Anticipated,Shanghai 10th People's Hospital,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-01T09:26:31Z,2020-05-01T09:26:31Z,5182843,NCT04328454,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-26,NA,NA,2020-04-09,2020-03-27,2020-03-30,Actual,NA,NA,NA,NA,NA,NA,2020-04-09,2020-04-10,Actual,"March 20, 2020",Actual,2020-03-20,April 2020,2020-04-30,"September 1, 2020",Anticipated,2020-09-01,"July 1, 2020",Anticipated,2020-07-01,NA,Observational,NA,,Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia,"Proflaxis for Healthcare Professionals Using Hydroxychloroquine Plus Vitamin Combining Vitamins C, D and Zinc During COVID-19 Pandemia: An Observational Study",Recruiting,NA,NA,80,Anticipated,Istinye University,,NA,1,NA,FALSE,NA,NA,NA,FALSE,TRUE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,NA,NA,2020-05-01T09:26:44Z,2020-05-01T09:26:44Z,5183068,NCT04326725,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-26,NA,NA,2020-04-16,2020-03-27,2020-03-30,Actual,NA,NA,NA,NA,NA,NA,2020-04-16,2020-04-20,Actual,"April 13, 2020",Actual,2020-04-13,April 2020,2020-04-30,"August 31, 2020",Anticipated,2020-08-31,"August 1, 2020",Anticipated,2020-08-01,NA,Interventional,NA,,ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection,"ODYSSEY: A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy of Tradipitant in Treating Inflammatory Lung Injury and Improving Clinical Outcomes Associated With Severe or Critical COVID-19 Infection",Enrolling by invitation,NA,Phase 3,300,Anticipated,Vanda Pharmaceuticals,,2,NA,NA,NA,NA,NA,NA,NA,TRUE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,NA,NA,2020-05-01T09:26:47Z,2020-05-01T09:26:47Z,5183106,NCT04326426,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-26,NA,NA,2020-03-30,2020-03-27,2020-03-30,Actual,NA,NA,NA,NA,NA,NA,2020-03-30,2020-04-01,Actual,"March 23, 2020",Actual,2020-03-23,March 2020,2020-03-31,"September 20, 2020",Anticipated,2020-09-20,"July 20, 2020",Anticipated,2020-07-20,NA,Observational,NA,,Active Monitoring And Determinants of Incidence Infection of COVDI-19,Active Monitoring And Determinants of Incidence Infection of COVDI-19 in a Hospital Population (AMADIICH) Study Protocol,Recruiting,NA,NA,1000,Anticipated,"FundaciÃ³n TeÃ³filo Hernando, Spain",,NA,1,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-01T09:26:47Z,2020-05-01T09:26:47Z,5183111,NCT04326400,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-26,NA,NA,2020-04-09,2020-03-27,2020-03-30,Actual,NA,NA,NA,NA,NA,NA,2020-04-09,2020-04-10,Actual,"April 6, 2020",Actual,2020-04-06,April 2020,2020-04-30,"October 7, 2021",Anticipated,2021-10-07,"April 7, 2021",Anticipated,2021-04-07,NA,Observational,COVIDx,,Evaluation of Novel Diagnostic Tests for COVID-19,Evaluation of Novel Diagnostic Tests for 2019-nCOV,Recruiting,NA,NA,200,Anticipated,Cambridge University Hospitals NHS Foundation Trust,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      Throat/Nasal Swab, Nasopharyngeal Swab, Endotracheal tube aspirate and whole blood-serum for
      viral-RNA analysis
    ",NA,NA,NA,Undecided,NA,2020-05-01T09:26:47Z,2020-05-01T09:26:47Z,5183113,NCT04326387,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-26,NA,NA,2020-03-26,2020-03-26,2020-03-30,Actual,NA,NA,NA,NA,NA,NA,2020-03-26,2020-03-30,Actual,"March 25, 2020",Actual,2020-03-25,March 2020,2020-03-31,"September 25, 2022",Anticipated,2022-09-25,"September 25, 2022",Anticipated,2022-09-25,NA,Observational,NA,,Audio Data Collection for Identification and Classification of Coughing,Audio Data Collection for Identification and Classification of Coughing,Recruiting,NA,NA,1000,Anticipated,HealthMode Inc.,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-01T09:26:48Z,2020-05-01T09:26:48Z,5183124,NCT04326309,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-24,NA,NA,2020-03-26,2020-03-26,2020-03-30,Actual,NA,NA,NA,NA,NA,NA,2020-03-26,2020-03-30,Actual,"February 24, 2020",Actual,2020-02-24,March 2020,2020-03-31,"June 17, 2021",Anticipated,2021-06-17,"February 28, 2021",Anticipated,2021-02-28,NA,Observational,NA,,Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong,"Comprehensive Clinical, Virological, Microbiological, Immunological and Laboratory Monitoring of Patients Hospitalized With Coronavirus Disease 2019 (COVID-19)",Recruiting,NA,NA,170,Anticipated,Chinese University of Hong Kong,,NA,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-01T09:26:51Z,2020-05-01T09:26:51Z,5183185,NCT04325919,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-25,NA,NA,2020-04-07,2020-03-27,2020-03-30,Actual,NA,NA,NA,NA,NA,NA,2020-04-07,2020-04-08,Actual,April 2020,Anticipated,2020-04-30,April 2020,2020-04-30,September 2020,Anticipated,2020-09-30,September 2020,Anticipated,2020-09-30,NA,Interventional,HYCOVID,,Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease,"Hydroxychloroquine Versus Placebo in Patients Presenting COVID-19 Infection and at Risk of Secondary Complication: a Prospective, Multicentre, Randomised, Double-blind Study",Recruiting,NA,Phase 3,1300,Anticipated,"University Hospital, Angers",,2,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-01T09:26:51Z,2020-05-01T09:26:51Z,5183193,NCT04325893,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-25,NA,NA,2020-04-10,2020-03-25,2020-03-27,Actual,NA,NA,NA,NA,NA,NA,2020-04-10,2020-04-14,Actual,"March 10, 2020",Actual,2020-03-10,April 2020,2020-04-30,"May 8, 2020",Anticipated,2020-05-08,"April 10, 2020",Anticipated,2020-04-10,NA,Observational,CORONADO,,"""COVID-19 and Diabetes Outcomes""","""Coronavirus SARS-CoV2 and Diabetes Outcomes"" : CORONADO",Recruiting,NA,NA,1000,Anticipated,Nantes University Hospital,,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-01T09:27:04Z,2020-05-01T09:27:04Z,5183362,NCT04324736,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-25,NA,NA,2020-03-27,2020-03-25,2020-03-27,Actual,NA,NA,NA,NA,NA,NA,2020-03-27,2020-03-31,Actual,"March 27, 2020",Actual,2020-03-27,March 2020,2020-03-31,"November 26, 2020",Anticipated,2020-11-26,"September 26, 2020",Anticipated,2020-09-26,NA,Interventional,CYCOV,,Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation,Recruiting,NA,N/A,30,Anticipated,University Hospital Freiburg,,2,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-01T09:27:05Z,2020-05-01T09:27:05Z,5183387,NCT04324528,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-25,NA,NA,2020-04-14,2020-03-25,2020-03-27,Actual,NA,NA,NA,NA,NA,NA,2020-04-14,2020-04-15,Actual,"March 27, 2020",Actual,2020-03-27,March 2020,2020-03-31,"December 31, 2021",Anticipated,2021-12-31,"March 27, 2021",Anticipated,2021-03-27,NA,Interventional,CORIMUNO-SARI,,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI,"Active, not recruiting",NA,Phase 2/Phase 3,239,Actual,Assistance Publique - HÃ´pitaux de Paris,,2,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Yes,NA,2020-05-01T09:27:08Z,2020-05-01T09:27:08Z,5183437,NCT04324073,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-25,NA,NA,2020-03-31,2020-03-25,2020-03-27,Actual,NA,NA,NA,NA,NA,NA,2020-03-31,2020-04-01,Actual,"March 27, 2020",Actual,2020-03-27,March 2020,2020-03-31,"December 31, 2021",Anticipated,2021-12-31,"March 27, 2021",Anticipated,2021-03-27,NA,Observational,CORIMUNO-19,,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients,Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients,Recruiting,NA,NA,1000,Anticipated,Assistance Publique - HÃ´pitaux de Paris,,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Yes,NA,2020-05-01T09:27:08Z,2020-05-01T09:27:08Z,5183441,NCT04324047,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-19,NA,NA,2020-04-13,2020-03-25,2020-03-26,Actual,NA,NA,NA,NA,NA,NA,2020-04-13,2020-04-15,Actual,"March 23, 2020",Actual,2020-03-23,April 2020,2020-04-30,"August 31, 2020",Anticipated,2020-08-31,"August 31, 2020",Anticipated,2020-08-31,NA,Interventional,CloroCOVID19,,Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2,"Efficacy and Safety of Chloroquine Diphosphate for the Treatment of Hospitalized Patients With Severe Acute Respiratory Syndrome Secondary to SARS-CoV2: a Phase IIb, Double-blind, Randomized Adaptive Clinical Trial",Recruiting,NA,Phase 2,440,Anticipated,FundaÃ§Ã£o de Medicina Tropical Dr. Heitor Vieira Dourado,,2,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,after study publication,upon request to researchers,NA,Yes,all patient data will be shared after study publication,2020-05-01T09:27:13Z,2020-05-01T09:27:13Z,5183517,NCT04323527,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-24,NA,NA,2020-03-28,2020-03-25,2020-03-26,Actual,NA,NA,NA,NA,NA,NA,2020-03-28,2020-03-31,Actual,"March 19, 2020",Actual,2020-03-19,March 2020,2020-03-31,"May 19, 2020",Anticipated,2020-05-19,"May 19, 2020",Anticipated,2020-05-19,NA,Observational,SISCO,,An Observational Case-control Study of the Use of Siltuximab in ARDS Patients Diagnosed With COVID-19 Infection,An Observational Case-control Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications,Recruiting,NA,NA,50,Anticipated,A.O. Ospedale Papa Giovanni XXIII,,NA,2,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-01T09:27:24Z,2020-05-01T09:27:24Z,5183718,NCT04322188,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-23,NA,NA,2020-04-10,2020-03-24,2020-03-25,Actual,NA,NA,NA,NA,NA,NA,2020-04-10,2020-04-14,Actual,"March 28, 2020",Actual,2020-03-28,April 2020,2020-04-30,November 2020,Anticipated,2020-11-30,August 2020,Anticipated,2020-08-31,NA,Interventional,NA,,The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients,The (Norwegian) NOR Solidarity Multicenter Trial on the Efficacy of Different Anti-viral Drugs in SARS-CoV-2 Infected Patients,Recruiting,NA,Phase 2/Phase 3,700,Anticipated,Oslo University Hospital,,3,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,The study will end according the requirements to WHO,WHO COVID 19 investigators,NA,Yes,All patients included in this study will automatically be included in the WHO COVID 19 protocol,2020-05-01T09:27:27Z,2020-05-01T09:27:27Z,5183779,NCT04321616,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-17,NA,NA,2020-03-18,2020-03-17,2020-03-19,Actual,NA,NA,NA,NA,NA,NA,2020-03-18,2020-03-20,Actual,"March 17, 2020",Actual,2020-03-17,March 2020,2020-03-31,"January 1, 2023",Anticipated,2023-01-01,"January 1, 2021",Anticipated,2021-01-01,NA,Observational,CovidTox,,Adverse Events Related to Treatments Used Against Coronavirus Disease 2019,Adverse Events Related to Treatments Used Against Coronavirus Disease 2019,Recruiting,NA,NA,1000,Anticipated,Groupe Hospitalier Pitie-Salpetriere,,NA,1,NA,FALSE,NA,NA,NA,FALSE,TRUE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,No,No individual data is available per se. They need to be retrieved from the World Health Organization.,2020-05-01T09:28:22Z,2020-05-01T09:28:22Z,5184648,NCT04314817,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-16,NA,NA,2020-03-16,2020-03-16,2020-03-19,Actual,NA,NA,NA,NA,NA,NA,2020-03-16,2020-03-19,Actual,"March 20, 2020",Anticipated,2020-03-20,March 2020,2020-03-31,"May 31, 2020",Anticipated,2020-05-31,"May 1, 2020",Anticipated,2020-05-01,3 Weeks,Observational [Patient Registry],NA,,The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia,The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia,Recruiting,NA,NA,80,Anticipated,Xiangya Hospital of Central South University,,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-01T09:28:25Z,2020-05-01T09:28:25Z,5184727,NCT04314271,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-13,NA,NA,2020-03-14,2020-03-14,2020-03-18,Actual,NA,NA,NA,NA,NA,NA,2020-03-14,2020-03-18,Actual,"February 1, 2020",Actual,2020-02-01,March 2020,2020-03-31,February 2021,Anticipated,2021-02-28,October 2020,Anticipated,2020-10-31,NA,Observational,SOTSPC,,Sequential Oxygen Therapy Strategy for Patients With COVID-19,Sequential Oxygen Therapy Strategy for Patients With COVID-19,Recruiting,NA,NA,30,Anticipated,Henan Provincial People's Hospital,,NA,3,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,No,NA,2020-05-01T09:28:40Z,2020-05-01T09:28:40Z,5185005,NCT04312100,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-10,NA,NA,2020-03-12,2020-03-12,2020-03-13,Actual,NA,NA,NA,NA,NA,NA,2020-03-12,2020-03-13,Actual,"March 11, 2020",Actual,2020-03-11,March 2020,2020-03-31,May 2020,Anticipated,2020-05-31,May 2020,Anticipated,2020-05-31,NA,Interventional,NA,,Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19),Randomized Controlled Clinical Trials of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19),Recruiting,NA,Phase 2,150,Anticipated,Asan Medical Center,,3,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-01T09:29:17Z,2020-05-01T09:29:17Z,5185614,NCT04307693,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-10,NA,NA,2020-04-04,2020-03-10,2020-03-12,Actual,NA,NA,NA,NA,NA,NA,2020-04-04,2020-04-07,Actual,"March 21, 2020",Actual,2020-03-21,April 2020,2020-04-30,"March 21, 2022",Anticipated,2022-03-21,"March 21, 2021",Anticipated,2021-03-21,NA,Interventional,NOSARSCOVID,,Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19,Nitric Oxide Gas Inhalation Therapy for Mechanically Ventilated Patients With Severe Acute Respiratory Syndrome Caused by SARS-CoV2: a Randomized Clinical Trial.,Recruiting,NA,Phase 2,200,Anticipated,Massachusetts General Hospital,,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,No,NA,2020-05-01T09:29:26Z,2020-05-01T09:29:26Z,5185770,NCT04306393,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-02-24,NA,NA,2020-04-05,2020-02-25,2020-02-28,Actual,NA,NA,NA,NA,NA,NA,2020-04-05,2020-04-07,Actual,"March 5, 2020",Actual,2020-03-05,April 2020,2020-04-30,"July 31, 2020",Anticipated,2020-07-31,"July 15, 2020",Anticipated,2020-07-15,NA,Interventional,NA,,Treatment With Mesenchymal Stem Cells for Severe Corona Virus Disease 2019(COVID-19),"A Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Human Mesenchymal Stem Cells in Combination With Standard Therapy in the Treatment of COVID-19 Patients With Severe Convalescence",Recruiting,NA,Phase 2,90,Anticipated,Beijing 302 Hospital,,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-01T09:32:01Z,2020-05-01T09:32:01Z,5187996,NCT04288102,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-02-13,NA,NA,2020-03-15,2020-02-20,2020-02-25,Actual,NA,NA,NA,NA,NA,NA,2020-03-15,2020-03-17,Actual,"February 21, 2020",Actual,2020-02-21,March 2020,2020-03-31,"July 30, 2020",Anticipated,2020-07-30,"May 30, 2020",Anticipated,2020-05-30,NA,Observational,NA,,Study for Novel Coronavirus Pneumonia (NCP),Study for Clinical Epidemiology and Methods of Diagnosis and Treatment of Novel Coronavirus Pneumonia (NCP),Recruiting,NA,NA,2000,Anticipated,"Wuhan Union Hospital, China",,NA,NA,NA,FALSE,NA,NA,NA,NA,TRUE,TRUE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-01T09:32:41Z,2020-05-01T09:32:41Z,5188629,NCT04283396,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-02-10,NA,NA,2020-02-21,2020-02-21,2020-02-25,Actual,NA,NA,NA,NA,NA,NA,2020-02-21,2020-02-25,Actual,"February 4, 2020",Actual,2020-02-04,February 2020,2020-02-29,"June 1, 2020",Anticipated,2020-06-01,"April 30, 2020",Anticipated,2020-04-30,NA,Interventional,NA,,A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection,"A Randomized, Open-label Study to Evaluate the Efficacy and Safety of Pirfenidone in Patients With Severe and Critical Novel Coronavirus Infection",Recruiting,NA,Phase 3,294,Anticipated,Tongji Hospital,,2,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-01T09:32:45Z,2020-05-01T09:32:45Z,5188697,NCT04282902,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-02-13,NA,NA,2020-04-11,2020-02-20,2020-02-21,Actual,NA,NA,NA,NA,NA,NA,2020-04-11,2020-04-14,Actual,"February 15, 2020",Actual,2020-02-15,February 2020,2020-02-29,"December 30, 2020",Anticipated,2020-12-30,"September 30, 2020",Anticipated,2020-09-30,NA,Interventional,NA,,NK Cells Treatment for COVID-19,Clinical Investigation of Natural Killer Cells Treatment in Pneumonia Patients Infected With 2019 Novel Coronavirus,Recruiting,NA,Phase 1,30,Anticipated,Xinxiang medical university,,2,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-01T09:33:10Z,2020-05-01T09:33:10Z,5189060,NCT04280224,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-02-19,NA,NA,2020-02-19,2020-02-19,2020-02-21,Actual,NA,NA,NA,NA,NA,NA,2020-02-19,2020-02-21,Actual,"January 20, 2020",Actual,2020-01-20,February 2020,2020-02-29,"February 28, 2021",Anticipated,2021-02-28,"January 31, 2021",Anticipated,2021-01-31,NA,Observational,NA,,Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations,Study on Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations in Patients,Recruiting,NA,NA,20,Anticipated,"Third Affiliated Hospital, Sun Yat-Sen University",,NA,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-01T09:33:14Z,2020-05-01T09:33:14Z,5189124,NCT04279795,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-02-15,NA,NA,2020-02-20,2020-02-19,2020-02-21,Actual,NA,NA,NA,NA,NA,NA,2020-02-20,2020-02-24,Actual,"January 20, 2020",Actual,2020-01-20,February 2020,2020-02-29,"February 28, 2021",Anticipated,2021-02-28,"January 31, 2021",Anticipated,2021-01-31,NA,Observational,NA,,Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection,Investigation on Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection in Isolation Unit,Recruiting,NA,NA,100,Anticipated,"Third Affiliated Hospital, Sun Yat-Sen University",,NA,2,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-01T09:33:14Z,2020-05-01T09:33:14Z,5189125,NCT04279782,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-02-05,NA,NA,2020-02-13,2020-02-05,2020-02-07,Actual,NA,NA,NA,NA,NA,NA,2020-02-13,2020-02-17,Actual,"February 4, 2020",Actual,2020-02-04,February 2020,2020-02-29,"February 4, 2021",Anticipated,2021-02-04,"October 4, 2020",Anticipated,2020-10-04,NA,Observational,Cov-CONTACT,,Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection,Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection,Recruiting,NA,NA,300,Anticipated,"Institut National de la SantÃ© Et de la Recherche MÃ©dicale, France",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples Without DNA,"
      Nasopharyngeal swabs
    ",NA,NA,NA,Undecided,NA,2020-05-01T09:36:32Z,2020-05-01T09:36:32Z,5191575,NCT04259892,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-01-30,NA,NA,2020-01-31,2020-01-31,2020-02-05,Actual,NA,NA,NA,NA,NA,NA,2020-01-31,2020-02-05,Actual,"January 28, 2020",Anticipated,2020-01-28,January 2020,2020-01-31,"July 31, 2020",Anticipated,2020-07-31,"May 30, 2020",Anticipated,2020-05-30,NA,Interventional,ELACOI,,The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection,"A Randomized, Open-label, Controlled Study of the Efficacy of Lopinavir Plus Ritonavir and Arbidol for Treating With Patients With Novel Coronavirus Infection",Recruiting,NA,Phase 4,125,Anticipated,Guangzhou 8th People's Hospital,,3,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,NA,NA,2020-05-01T09:37:37Z,2020-05-01T09:37:37Z,5192391,NCT04252885,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-04-05,NA,NA,2020-04-22,2020-04-09,2020-04-15,Actual,NA,NA,NA,NA,NA,NA,2020-04-22,2020-04-24,Actual,"April 11, 2020",Actual,2020-04-11,April 2020,2020-04-30,"April 6, 2021",Anticipated,2021-04-06,"September 6, 2020",Anticipated,2020-09-06,NA,Interventional,COVIDOC,,Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial),Randomized Trial Assessing Efficacy and Safety of Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for Hospitalized Adults With COVID-19 Pneumonia,Recruiting,NA,Phase 2/Phase 3,150,Anticipated,"University Hospital, Montpellier",,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-04T09:05:07Z,2020-05-04T09:05:07Z,5776796,NCT04345861,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-02-20,NA,NA,2020-02-20,2020-02-20,2020-02-21,Actual,NA,NA,NA,NA,NA,NA,2020-02-20,2020-02-21,Actual,"February 22, 2020",Anticipated,2020-02-22,February 2020,2020-02-29,"July 1, 2020",Anticipated,2020-07-01,"July 1, 2020",Anticipated,2020-07-01,NA,Interventional,NA,,Fingolimod in COVID-19,Efficacy of Fingolimod in the Treatment of New Coronavirus Pneumonia (COVID-19),Recruiting,NA,Phase 2,30,Anticipated,First Affiliated Hospital of Fujian Medical University,,2,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Yes,NA,2020-05-01T09:33:07Z,2020-05-01T09:33:07Z,5189016,NCT04280588,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-04-02,NA,NA,2020-04-02,2020-04-02,2020-04-06,Actual,NA,NA,NA,NA,NA,NA,2020-04-02,2020-04-06,Actual,"March 30, 2020",Actual,2020-03-30,April 2020,2020-04-30,"September 30, 2023",Anticipated,2023-09-30,"September 30, 2021",Anticipated,2021-09-30,NA,Interventional,NA,,Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care,Randomized Study to Evaluate the Safety and Antiviral Efficacy of Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care Treatment,Enrolling by invitation,NA,Phase 4,1250,Anticipated,Providence Health & Services,,2,NA,NA,FALSE,NA,NA,NA,FALSE,TRUE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,Undecided,NA,2020-05-01T09:25:39Z,2020-05-01T09:25:39Z,5182093,NCT04334967,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-04-07,NA,NA,2020-04-14,2020-04-09,2020-04-10,Actual,NA,NA,NA,NA,NA,NA,2020-04-14,2020-04-16,Actual,"April 14, 2020",Anticipated,2020-04-14,April 2020,2020-04-30,April 2023,Anticipated,2023-04-30,April 2022,Anticipated,2022-04-30,NA,Interventional,NA,,University of Utah COVID-19 Hydrochloroquine Trial,Hydroxychloroquine for Outpatients With Confirmed COVID-19,Recruiting,NA,Phase 2,400,Anticipated,University of Utah,,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,No,NA,2020-05-01T09:24:43Z,2020-05-01T09:24:43Z,5181249,NCT04342169,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-23,NA,NA,2020-04-18,2020-03-24,2020-03-26,Actual,NA,NA,NA,NA,NA,NA,2020-04-18,2020-04-21,Actual,"April 15, 2020",Anticipated,2020-04-15,April 2020,2020-04-30,"January 15, 2021",Anticipated,2021-01-15,"December 15, 2020",Anticipated,2020-12-15,NA,Interventional,NA,,Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus,"The Efficacy of Natural Honey in Patients Infected With Novel Coronavirus (COVID-19) : A Randomized, Controlled ,Single Masked , Investigator Initiated, Multi-center Trial",Recruiting,NA,Phase 3,1000,Anticipated,Misr University for Science and Technology,,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-01T09:27:14Z,2020-05-01T09:27:14Z,5183540,NCT04323345,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-02-25,NA,NA,2020-02-28,2020-02-28,2020-03-03,Actual,NA,NA,NA,NA,NA,NA,2020-02-28,2020-03-03,Actual,"February 1, 2020",Actual,2020-02-01,February 2020,2020-02-29,"December 31, 2020",Anticipated,2020-12-31,"July 31, 2020",Anticipated,2020-07-31,NA,Observational,NA,,Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19,The Efficacy and Safety of Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of Novel Coronavirus Pneumonia Patient (COVID-19) : An Observational Study,Recruiting,NA,NA,15,Anticipated,Shanghai Public Health Clinical Center,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-01T09:31:22Z,2020-05-01T09:31:22Z,5187445,NCT04292340,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-02-23,NA,NA,2020-02-29,2020-02-29,2020-03-03,Actual,NA,NA,NA,NA,NA,NA,2020-02-29,2020-03-03,Actual,"January 1, 2020",Actual,2020-01-01,February 2020,2020-02-29,"July 31, 2020",Anticipated,2020-07-31,"April 30, 2020",Anticipated,2020-04-30,NA,Observational,2019-nCoV,,Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus,Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus(2019-nCoV),"Active, not recruiting",NA,NA,400,Anticipated,Fujian Provincial Hospital,,NA,3,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-01T09:31:22Z,2020-05-01T09:31:22Z,5187446,NCT04292327,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-02-14,NA,NA,2020-04-01,2020-02-16,2020-02-19,Actual,NA,NA,NA,NA,NA,NA,2020-04-01,2020-04-03,Actual,"February 15, 2020",Actual,2020-02-15,February 2020,2020-02-29,May 2020,Anticipated,2020-05-31,April 2020,Anticipated,2020-04-30,NA,Interventional,BEST-CP,,Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia,A Pilot Study of Bevacizumab in the Treatment of Severe or Critical Patients With COVID-19 Pneumonia (BEST-CP),Recruiting,NA,Phase 2/Phase 3,20,Anticipated,Qilu Hospital of Shandong University,,1,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-01T09:33:51Z,2020-05-01T09:33:51Z,5189646,NCT04275414,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-02-16,NA,NA,2020-04-07,2020-02-16,2020-02-18,Actual,NA,NA,NA,NA,NA,NA,2020-04-07,2020-04-08,Actual,"February 19, 2020",Actual,2020-02-19,April 2020,2020-04-30,July 2020,Anticipated,2020-07-31,"April 4, 2020",Actual,2020-04-04,NA,Observational,NA,,Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool,Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool (COV_NUTRIC),"Active, not recruiting",NA,NA,117,Actual,Peking University Third Hospital,,NA,2,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-01T09:34:07Z,2020-05-01T09:34:07Z,5189792,NCT04274322,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 08, 2020",2020-04-23,NA,NA,2020-04-28,2020-04-28,2020-04-29,Actual,NA,NA,NA,NA,NA,NA,2020-04-28,2020-04-29,Actual,"April 6, 2020",Actual,2020-04-06,April 2020,2020-04-30,"April 23, 2020",Actual,2020-04-23,"April 23, 2020",Actual,2020-04-23,NA,Interventional,PIC-19,,Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19,Platelet Inhibition With GP IIb/IIIa Inhibitor in Critically Ill Patients With Coronavirus Disease 2019 (COVID-19). A Compassionate Use Protocol,Completed,NA,Phase 2,5,Actual,University of Milan,,1,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,No,NA,2020-05-09T09:10:51Z,2020-05-09T09:10:51Z,5832587,NCT04368377,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 08, 2020",2020-04-17,NA,NA,2020-04-28,2020-04-28,2020-04-29,Actual,NA,NA,NA,NA,NA,NA,2020-04-28,2020-04-29,Actual,"March 8, 2020",Actual,2020-03-08,April 2020,2020-04-30,"May 31, 2020",Anticipated,2020-05-31,"May 31, 2020",Anticipated,2020-05-31,NA,Observational,NA,,Social Media and COVID-19,Getting it Right: Towards Responsible Social Media Use During a Pandemic (COVID-19),Recruiting,NA,NA,150,Anticipated,Yale-NUS College,,NA,1,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,"Due to stipulations by the Institutional Review Board, data cannot be shared.",2020-05-09T09:11:27Z,2020-05-09T09:11:27Z,5832701,NCT04367363,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 08, 2020",2020-04-25,NA,NA,2020-04-27,2020-04-25,2020-04-28,Actual,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-29,Actual,"April 20, 2020",Actual,2020-04-20,April 2020,2020-04-30,"April 20, 2025",Anticipated,2025-04-20,"June 1, 2020",Anticipated,2020-06-01,5 Years,Observational [Patient Registry],COV-CREM,,Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19),Ã‰tude Des rÃ©ponses Immunitaires Lymphocytaires spÃ©cifiques Chez Des Patients infectÃ©s Par le Virus SARS-CoV-2 : CaractÃ©ristiques Des RÃ©ponses Effectrices et MÃ©moires,Recruiting,NA,NA,60,Anticipated,Centre Hospitalier Universitaire de Besancon,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-09T09:12:12Z,2020-05-09T09:12:12Z,5832851,NCT04365322,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 08, 2020",2020-04-23,NA,NA,2020-04-27,2020-04-23,2020-04-27,Actual,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-29,Actual,"April 27, 2020",Actual,2020-04-27,April 2020,2020-04-30,"August 3, 2020",Anticipated,2020-08-03,"July 6, 2020",Anticipated,2020-07-06,NA,Interventional,HCQPreP,,Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP),Hydroxychloroquine as Primary Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP),Recruiting,NA,Phase 3,1700,Anticipated,Louisiana State University Health Sciences Center in New Orleans,,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-09T09:12:26Z,2020-05-09T09:12:26Z,5832911,NCT04363450,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 08, 2020",2020-04-23,NA,NA,2020-04-27,2020-04-23,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-29,Actual,"April 21, 2020",Actual,2020-04-21,April 2020,2020-04-30,"December 21, 2024",Anticipated,2024-12-21,"December 31, 2022",Anticipated,2022-12-31,NA,Observational,LIINC,,Long-term Impact of Infection With Novel Coronavirus (COVID-19),Long-term Impact of Infection With Novel Coronavirus (LIINC): An Observational Study,Recruiting,NA,NA,800,Anticipated,"University of California, San Francisco",,NA,1,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      Whole blood, peripheral blood mononuclear cells, plasma, serum, and saliva.
    ",NA,NA,NA,No,NA,2020-05-09T09:13:37Z,2020-05-09T09:13:37Z,5832949,NCT04362150,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 08, 2020",2020-03-13,NA,NA,2020-04-28,2020-03-18,2020-03-20,Actual,NA,NA,NA,NA,NA,NA,2020-04-28,2020-04-29,Actual,"March 22, 2020",Actual,2020-03-22,March 2020,2020-03-31,March 2023,Anticipated,2023-03-31,March 2023,Anticipated,2023-03-31,NA,Interventional,DisCoVeRy,,Trial of Treatments for COVID-19 in Hospitalized Adults,"Multi-centre, Adaptive, Randomized Trial of the Safety and Efficacy of Treatments of COVID-19 in Hospitalized Adults",Recruiting,NA,Phase 3,3100,Anticipated,"Institut National de la SantÃ© Et de la Recherche MÃ©dicale, France",,5,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-09T09:15:50Z,2020-05-09T09:15:50Z,5833422,NCT04315948,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 08, 2020",2020-04-27,NA,NA,2020-04-27,2020-04-27,2020-04-29,Actual,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-29,Actual,"April 1, 2020",Actual,2020-04-01,April 2020,2020-04-30,"December 31, 2020",Anticipated,2020-12-31,"June 30, 2020",Anticipated,2020-06-30,7 Days,Observational [Patient Registry],IMSEQ,,COVID-19 Immune Repertoire Sequencing,COVID-19 Immune Repertoire Sequencing,Recruiting,NA,NA,100,Anticipated,"Institute of Tropical Medicine, Belgium",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-09T09:10:59Z,2020-05-09T09:10:59Z,5832612,NCT04368143,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 08, 2020",2020-03-26,NA,NA,2020-04-27,2020-03-26,2020-03-27,Actual,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-29,Actual,"March 13, 2020",Actual,2020-03-13,April 2020,2020-04-30,"February 28, 2023",Anticipated,2023-02-28,"February 28, 2021",Anticipated,2021-02-28,NA,Observational,CORSER,,Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France,Sero-epidemiological Study of the SARS-CoV-2 Virus in France: Constitution of a Collection of Human Biological Samples,Recruiting,NA,NA,1000,Anticipated,Institut Pasteur,,NA,6,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,Samples With DNA,"
      serum, plasma
    ",NA,NA,NA,Undecided,NA,2020-05-09T09:15:35Z,2020-05-09T09:15:35Z,5833354,NCT04325646,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-28,NA,NA,2020-04-29,2020-04-29,2020-04-30,Actual,NA,NA,NA,NA,NA,NA,2020-04-29,2020-04-30,Actual,"April 14, 2020",Actual,2020-04-14,April 2020,2020-04-30,"April 14, 2021",Anticipated,2021-04-14,"April 14, 2021",Anticipated,2021-04-14,NA,Observational,NA,,Observational Study of COVID-19 Treatment Efficacy,Observational Study of COVID-19 Treatment Efficacy,Enrolling by invitation,NA,NA,1000,Anticipated,OSF Healthcare System,,NA,4,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-11T18:31:15Z,2020-05-11T18:31:15Z,5876284,NCT04369989,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-22,NA,NA,2020-04-28,2020-04-22,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-28,2020-04-30,Actual,May 2020,Anticipated,2020-05-31,April 2020,2020-04-30,October 2020,Anticipated,2020-10-31,October 2020,Anticipated,2020-10-31,NA,Interventional,LAPTRANSCOV,,Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients,Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum During an Emergency Laparoscopy Conducted on Confirmed or Suspected COVID-19 Patients,Recruiting,NA,N/A,40,Anticipated,Centre Hospitalier RenÃ© Dubos,,1,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-11T18:33:04Z,2020-05-11T18:33:04Z,5876657,NCT04361396,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-22,NA,NA,2020-04-28,2020-04-22,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-28,2020-04-30,Actual,April 2020,Anticipated,2020-04-30,April 2020,2020-04-30,December 2021,Anticipated,2021-12-31,December 2021,Anticipated,2021-12-31,NA,Observational,NA,,Atrium COVID-19 Syndromic and Serologic Surveillance,"A Prospective Study of COVID-19 Using Real-Time Syndromic Surveillance, Scheduled At-home Serologic Testing, and Electronic Health Records",Enrolling by invitation,NA,NA,450000,Anticipated,Atrium Health,,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-11T18:33:05Z,2020-05-11T18:33:05Z,5876659,NCT04361123,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-21,NA,NA,2020-04-28,2020-04-21,2020-04-24,Actual,NA,NA,NA,NA,NA,NA,2020-04-28,2020-04-30,Actual,"April 21, 2020",Actual,2020-04-21,April 2020,2020-04-30,April 2021,Anticipated,2021-04-30,December 2020,Anticipated,2020-12-31,NA,Interventional,NA,,Plasma Therapy of COVID-19 in Critically Ill Patients,"A Phase 2, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Human Anti-SARS-CoV-2 Convalescent Plasma in Severely Ill Adults With COVID-19",Recruiting,NA,Phase 2,105,Anticipated,Columbia University,,2,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-11T18:33:12Z,2020-05-11T18:33:12Z,5876682,NCT04359810,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-03-23,NA,NA,2020-04-28,2020-03-24,2020-03-25,Actual,NA,NA,NA,NA,NA,NA,2020-04-28,2020-04-30,Actual,"April 4, 2020",Actual,2020-04-04,March 2020,2020-03-31,"May 1, 2021",Anticipated,2021-05-01,"December 31, 2020",Anticipated,2020-12-31,NA,Interventional,CamoCO-19,,The Impact of Camostat Mesilate on COVID-19 Infection,"The Impact of Camostat Mesilate on COVID-19 Infection: An Investigator-initiated Randomized, Placebo-controlled, Phase IIa Trial",Recruiting,NA,Phase 1/Phase 2,580,Anticipated,University of Aarhus,,2,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,Access to the data sharing will be given to researchers who provide a methodologically sound proposal for any type of analysis and requires IRB/Ethics committee approval (if applicable). Proposals should be addressed to olesoega@rm.dk.,NA,Yes,"Data sharing plan: Individual deidentified participant data (including data dictionaries) will be shared following the publication of the primary and secondary endpoints as outlined in this protocol. Data to be shared includes deidentified data points in published, peer-reviewed articles. Additional, related documents will also be available (study protocol, informed consent form, statistical analysis plan). Data will become available following publication with no planned end date.",2020-05-11T18:35:13Z,2020-05-11T18:35:13Z,5877048,NCT04321096,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-04-13,NA,NA,2020-04-15,2020-04-13,2020-04-16,Actual,NA,NA,NA,NA,NA,NA,2020-04-15,2020-04-17,Actual,"April 12, 2020",Actual,2020-04-12,April 2020,2020-04-30,"May 13, 2020",Anticipated,2020-05-13,"May 13, 2020",Anticipated,2020-05-13,NA,Interventional,Ruxo-Sim-20,,Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.,Randomized Phase II Clinical Trial of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19.Ruxo-Sim-20 Clinical Trial.,Recruiting,NA,Phase 2,94,Anticipated,FundaciÃ³n de investigaciÃ³n HM,,2,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-01T09:23:55Z,2020-05-01T09:23:55Z,5180591,NCT04348695,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 07, 2020",2020-04-22,NA,NA,2020-04-27,2020-04-27,2020-04-28,Actual,NA,NA,NA,NA,NA,NA,2020-04-27,2020-04-28,Actual,"March 26, 2020",Actual,2020-03-26,April 2020,2020-04-30,"December 31, 2020",Anticipated,2020-12-31,"October 30, 2020",Anticipated,2020-10-30,NA,Interventional,PROBIOZOVID,,Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora,Oxygen-Ozone as Adjuvant Treatment in Early Control of Disease Progression in Patients With COVID-19 Associated With Modulation of the Gut Microbial Flora,Recruiting,NA,Phase 2,152,Anticipated,Azienda Policlinico Umberto I,,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-08T09:13:22Z,2020-05-08T09:13:22Z,5819983,NCT04366089,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-04-10,NA,NA,2020-04-21,2020-04-16,2020-04-17,Actual,NA,NA,NA,NA,NA,NA,2020-04-21,2020-04-24,Actual,"April 16, 2020",Actual,2020-04-16,April 2020,2020-04-30,"December 31, 2020",Anticipated,2020-12-31,"December 1, 2020",Anticipated,2020-12-01,NA,Interventional,ACOVACT,,Austrian CoronaVirus Adaptive Clinical Trial (COVID-19),"A Multicenter, Randomized, Active Controlled, Open Label, Platform Trial on the Efficacy and Safety of Experimental Therapeutics for Patients With COVID-19 (Caused by Infection With Severe Acute Respiratory Syndrome Coronavirus-2)",Recruiting,NA,Phase 2/Phase 3,500,Anticipated,Medical University of Vienna,,9,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,Anonymized and pseudonymized data will be published in peer reviewed journals and may be presented at congresses and conferences,2020-05-04T09:04:36Z,2020-05-04T09:04:36Z,5776726,NCT04351724,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-04-15,NA,NA,2020-04-22,2020-04-15,2020-04-17,Actual,NA,NA,NA,NA,NA,NA,2020-04-22,2020-04-24,Actual,"April 9, 2020",Actual,2020-04-09,April 2020,2020-04-30,April 2022,Anticipated,2022-04-30,April 2022,Anticipated,2022-04-30,NA,Observational,NA,,A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19,A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City,Recruiting,NA,NA,10000,Anticipated,"University Hospital, Basel, Switzerland",,NA,2,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-04T09:04:38Z,2020-05-04T09:04:38Z,5776727,NCT04351503,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-04-15,NA,NA,2020-04-15,2020-04-15,2020-04-20,Actual,NA,NA,NA,NA,NA,NA,2020-04-15,2020-04-20,Actual,April 2020,Anticipated,2020-04-30,April 2020,2020-04-30,December 2020,Anticipated,2020-12-31,November 2020,Anticipated,2020-11-30,NA,Observational,CALYPSO,,WGS ANALYSIS OF SARS-COV-2 POSITIVE PATIENTS,WHOLE GENOME SEQUENCING ANALYSIS OF SARS-COV-2 POSITIVE PATIENTS,Enrolling by invitation,NA,NA,5000,Anticipated,Vanda Pharmaceuticals,,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Yes,NA,2020-05-01T09:23:20Z,2020-05-01T09:23:20Z,5180051,NCT04353401,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-05-01,NA,NA,2020-05-06,2020-05-06,2020-05-07,Actual,NA,NA,NA,NA,NA,NA,2020-05-06,2020-05-07,Actual,"May 1, 2020",Actual,2020-05-01,May 2020,2020-05-31,"May 8, 2020",Anticipated,2020-05-08,"May 7, 2020",Anticipated,2020-05-07,NA,Interventional,NA,,Social Media and Covid19 Pandemic,The Role of Social Media as an Information Source in Covid19 Pandemic,Enrolling by invitation,NA,N/A,212,Anticipated,Acibadem University,,1,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,if requested to.,2020-05-12T09:12:22Z,2020-05-12T09:12:22Z,5887513,NCT04378738,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-05-03,NA,NA,2020-05-04,2020-05-04,2020-05-05,Actual,NA,NA,NA,NA,NA,NA,2020-05-04,2020-05-05,Actual,"May 4, 2020",Anticipated,2020-05-04,May 2020,2020-05-31,December 2021,Anticipated,2021-12-31,December 2020,Anticipated,2020-12-31,NA,Interventional,NA,,Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection,Efficacy and Safety of Early Anti-SARS-COV-2 Convalescent Plasma in Patients Admitted for COVID-19 Infection: a Randomized Phase II Trial,Recruiting,NA,Phase 2,30,Anticipated,Pontificia Universidad Catolica de Chile,,2,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-12T09:15:27Z,2020-05-12T09:15:27Z,5887917,NCT04375098,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-27,NA,NA,2020-05-06,2020-05-01,2020-05-05,Actual,NA,NA,NA,NA,NA,NA,2020-05-06,2020-05-08,Actual,"May 5, 2020",Anticipated,2020-05-05,May 2020,2020-05-31,"April 5, 2021",Anticipated,2021-04-05,"April 5, 2021",Anticipated,2021-04-05,NA,Interventional,NA,,Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia,Efficacy and Safety of High-Titer Anti-SARS-CoV-2 (COVID19) Convalescent Plasma for Hospitalized Patients With Infection Due to COVID-19 to Decrease Complications: A Phase II Trial,Recruiting,NA,Phase 2,29,Anticipated,University of Virginia,,1,NA,NA,FALSE,NA,NA,NA,TRUE,TRUE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-12T09:15:45Z,2020-05-12T09:15:45Z,5887997,NCT04374565,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-24,NA,NA,2020-05-04,2020-04-24,2020-04-27,Actual,NA,NA,NA,NA,NA,NA,2020-05-04,2020-05-06,Actual,"May 4, 2020",Actual,2020-05-04,May 2020,2020-05-31,"November 4, 2020",Anticipated,2020-11-04,"November 4, 2020",Anticipated,2020-11-04,NA,Interventional,ROCOCO,,Serology COVID-19 From the Cornwall Hospital Union,Serology COVID-19 From the Cornwall Hospital Union,Recruiting,NA,N/A,3200,Anticipated,Centre Hospitalier de Cornouaille,,3,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-12T09:19:26Z,2020-05-12T09:19:26Z,5888623,NCT04363593,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-04-06,NA,NA,2020-05-04,2020-04-17,2020-04-20,Actual,NA,NA,NA,NA,NA,NA,2020-05-04,2020-05-06,Actual,"April 21, 2020",Actual,2020-04-21,April 2020,2020-04-30,August 2020,Anticipated,2020-08-31,August 2020,Anticipated,2020-08-31,3 Months,Observational [Patient Registry],NA,,Renal Outcome in Patients With COVID-19,Renal Outcome in Patients With Coronavirus Disease 2019 (COVID-19),Recruiting,NA,NA,50,Anticipated,University of Giessen,,NA,2,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-12T09:20:15Z,2020-05-12T09:20:15Z,5888726,NCT04353583,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 11, 2020",2020-03-25,NA,NA,2020-05-05,2020-03-27,2020-03-31,Actual,NA,NA,NA,NA,NA,NA,2020-05-05,2020-05-07,Actual,"March 30, 2020",Actual,2020-03-30,May 2020,2020-05-31,"March 30, 2022",Anticipated,2022-03-30,"October 30, 2020",Anticipated,2020-10-30,NA,Interventional,BRACE,,BCG Vaccination to Protect Healthcare Workers Against COVID-19,BCG Vaccination to Reduce the Impact of COVID-19 in Australian Healthcare Workers Following Coronavirus Exposure (BRACE) Trial,Recruiting,NA,Phase 3,4170,Anticipated,Murdoch Childrens Research Institute,,2,NA,NA,FALSE,NA,NA,NA,NA,FALSE,FALSE,NA,NA,NA,NA,,"Beginning 6 months following analysis and article publications, for long-term use","Researchers from a recognised research institution whose proposed use of the data has been ethically reviewed and approved by an independent committee and who accept MCRI's conditions, under a collaborator agreement",NA,Yes,"Beginning 6 months following analysis and article publications, the following may be made available long-term for use by future researchers from a recognised research institution whose proposed use of the data has been ethically reviewed and approved by an independent committee and who accept MCRI's conditions, under a collaborator agreement, for accessing:
Individual participant data that underlie the results reported in our articles after de-identification (text, tables, figures and appendices)
Study protocol, Statistical Analysis Plan, Participant Informed Consent Form (PICF)",2020-05-12T09:21:32Z,2020-05-12T09:21:32Z,5888949,NCT04327206,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-04-01,NA,NA,2020-04-06,2020-04-01,2020-04-03,Actual,NA,NA,NA,NA,NA,NA,2020-04-06,2020-04-08,Actual,"March 27, 2020",Actual,2020-03-27,March 2020,2020-03-31,September 2020,Anticipated,2020-09-30,September 2020,Anticipated,2020-09-30,NA,Observational,TOVID-49,,Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19,Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19,Recruiting,NA,NA,100,Anticipated,"University Hospital, Angers",,NA,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,NA,NA,2020-05-01T09:25:48Z,2020-05-01T09:25:48Z,5182222,NCT04333849,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-02-11,NA,NA,2020-04-13,2020-02-17,2020-02-19,Actual,NA,NA,NA,NA,NA,NA,2020-04-13,2020-04-15,Actual,"February 10, 2020",Actual,2020-02-10,April 2020,2020-04-30,"March 31, 2020",Actual,2020-03-31,"March 30, 2020",Actual,2020-03-30,NA,Interventional,NA,,"Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment","An Open-label Randomized Controlled Trial on Lopinavir/ Ritonavir, Ribavirin and Interferon Beta 1b Combination Versus Lopinavir/ Ritonavir Alone, as Treatment for 2019 Novel Coronavirus Infection",Completed,NA,Phase 2,127,Actual,The University of Hong Kong,,2,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-01T09:33:40Z,2020-05-01T09:33:40Z,5189492,NCT04276688,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-04-08,NA,NA,2020-04-10,2020-04-10,2020-04-14,Actual,NA,NA,NA,NA,NA,NA,2020-04-10,2020-04-14,Actual,"April 1, 2020",Actual,2020-04-01,April 2020,2020-04-30,"May 1, 2020",Anticipated,2020-05-01,"April 15, 2020",Anticipated,2020-04-15,NA,Interventional,ProCov,,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study,Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study (ProCov),Recruiting,NA,N/A,25,Anticipated,Centre Hospitalier Intercommunal Aix-Pertuis,,1,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,No,NA,2020-05-01T09:24:30Z,2020-05-01T09:24:30Z,5181048,NCT04344106,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-04-04,NA,NA,2020-04-08,2020-04-08,2020-04-10,Actual,NA,NA,NA,NA,NA,NA,2020-04-08,2020-04-10,Actual,"April 4, 2020",Actual,2020-04-04,April 2020,2020-04-30,"August 1, 2021",Anticipated,2021-08-01,"April 1, 2021",Anticipated,2021-04-01,NA,Interventional,WU352,,"Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection","WU 352: Open-label, Randomized Controlled Trial of Hydroxychloroquine Alone or Hydroxychloroquine Plus Azithromycin or Chloroquine Alone or Chloroquine Plus Azithromycin in the Treatment of SARS CoV-2 Infection",Recruiting,NA,Phase 3,500,Anticipated,Washington University School of Medicine,,4,NA,NA,FALSE,NA,NA,NA,FALSE,TRUE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,No,NA,2020-05-01T09:24:47Z,2020-05-01T09:24:47Z,5181306,NCT04341727,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 08, 2020",2020-04-24,NA,NA,2020-04-28,2020-04-28,2020-04-29,Actual,NA,NA,NA,NA,NA,NA,2020-04-28,2020-04-29,Actual,"April 23, 2020",Actual,2020-04-23,April 2020,2020-04-30,"July 1, 2020",Anticipated,2020-07-01,"June 1, 2020",Anticipated,2020-06-01,NA,Interventional,RESCUE 1-19,,Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19,The RESCUE 1-19 Trial: Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19,Recruiting,NA,Phase 1/Phase 2,10,Anticipated,Emory University,,1,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,TRUE,NA,NA,NA,NA,,NA,NA,NA,No,"No
Results of the trial and not individual patient data will be shared. The study protocol, consent, and investigator's brochure will be available. The statistical plan is incorporated into the protocol, along with inclusion and exclusion criteria.",2020-05-09T09:11:50Z,2020-05-09T09:11:50Z,5832770,NCT04366791,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on May 01, 2020",2020-03-25,NA,NA,2020-04-21,2020-03-25,2020-03-27,Actual,NA,NA,NA,NA,NA,NA,2020-04-21,2020-04-24,Actual,"April 21, 2020",Actual,2020-04-21,April 2020,2020-04-30,"December 31, 2020",Anticipated,2020-12-31,"September 30, 2020",Anticipated,2020-09-30,NA,Interventional,ACT COVID19,,Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial,"Anti-Coronavirus Therapies to Prevent Progression of COVID-19, a Randomized Trial",Recruiting,NA,Phase 3,1500,Anticipated,Population Health Research Institute,,4,NA,NA,FALSE,NA,NA,NA,TRUE,FALSE,FALSE,NA,NA,FALSE,NA,,NA,NA,NA,Undecided,NA,2020-05-04T09:06:22Z,2020-05-04T09:06:22Z,5777032,NCT04324463,Coronavirus Infections,coronavirus infections
"ClinicalTrials.gov processed this data on April 30, 2020",2020-03-21,NA,NA,2020-03-30,2020-03-21,2020-03-24,Actual,NA,NA,NA,NA,NA,NA,2020-03-30,2020-03-31,Actual,"January 21, 2020",Actual,2020-01-21,March 2020,2020-03-31,June 2020,Anticipated,2020-06-30,May 2020,Anticipated,2020-05-31,NA,Interventional,NA,,Experimental Trial of rhIFNÎ± Nasal Drops to Prevent 2019-nCOV in Medical Staff,An Clinic Trial of Recombinant Human Interferon Alpha Nasal Drops to Prevent Coronavirus Disease 2019 in Medical Staff in Epidemic Area,Recruiting,NA,Phase 3,2944,Anticipated,Shanghai Jiao Tong University School of Medicine,,2,NA,NA,FALSE,NA,NA,NA,FALSE,FALSE,FALSE,NA,NA,NA,NA,,NA,NA,NA,Undecided,NA,2020-05-01T09:27:38Z,2020-05-01T09:27:38Z,5183977,NCT04320238,Coronavirus Infections,coronavirus infections
